0001493152-19-017289.txt : 20191114 0001493152-19-017289.hdr.sgml : 20191114 20191114122756 ACCESSION NUMBER: 0001493152-19-017289 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36159 FILM NUMBER: 191218245 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2019

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                to               

 

Commission File Number: 001-36159

 

STEREOTAXIS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   94-3120386

(State of
Incorporation)

 

(I.R.S. employer
identification no.)

     

4320 Forest Park Avenue Suite 100
St. Louis, Missouri

  63108
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (314) 678-6100

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [  ] No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Registration S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X] Yes [  ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer [  ] Accelerated filer [  ]
       
Non-accelerated filer [  ]     (Do not check if a smaller reporting company) Smaller reporting company [X]
       
    Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b -2 of the Exchange Act). [  ] Yes [X] No

 

The number of outstanding shares of the registrant’s common stock on October 31, 2019 was 66,721,079.

 

 

 

 
 

 

STEREOTAXIS, INC.

INDEX TO FORM 10-Q

 

    Page
     
Part I Financial Information  
   
Item 1. Financial Statements (unaudited)  
  Balance Sheets 3
  Statements of Operations 4
  Statements of Equity 5-6
  Statements of Cash Flows 7
  Notes to Financial Statements 8-16
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17-22
Item 3. [Reserved] 23
Item 4. Controls and Procedures 23
     
Part II Other Information  
Item 1. Legal Proceedings 23
Item 1A. Risk Factors 23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23
Item 3. Defaults upon Senior Securities 23
Item 4. [Reserved] 23
Item 5. Other Information 23
Item 6. Exhibits 23
Signatures 24

 

2
 

 

ITEM 1. FINANCIAL STATEMENTS

 

STEREOTAXIS, INC.

BALANCE SHEETS

 

   September 30,2019   December 31, 2018 
   (Unaudited)     
Assets          
Current assets:          
Cash and cash equivalents  $31,650,559   $10,796,072 
Accounts receivable, net of allowance of $368,191 and $398,847 in 2019 and 2018, respectively   3,830,395    5,021,111 
Inventories, net   1,546,716    1,191,666 
Prepaid expenses and other current assets   1,022,322    963,700 
Total current assets   38,049,992    17,972,549 
Property and equipment, net   270,751    343,693 
Operating lease right-of-use assets   4,771,187    - 
Other assets   214,042    198,365 
Total assets  $43,305,972   $18,514,607 
           
Liabilities and stockholders’ equity          
Current liabilities:          
Accounts payable  $1,031,975   $1,726,360 
Accrued liabilities   2,641,254    2,642,481 
Deferred revenue   5,283,783    5,825,536 
Current portion of operating lease liabilities   2,235,465    - 
Total current liabilities   11,192,477    10,194,377 
Long-term deferred revenue   560,508    407,151 
Operating lease liabilities   2,574,469    - 
Other liabilities   260,947    641,461 
Total liabilities   14,588,401    11,242,989 
           
Series A - Convertible preferred stock:          
Convertible preferred stock, Series A, par value $0.001; 23,780 and 23,900 shares outstanding at 2019 and 2018   5,929,749    5,960,475 
           
Stockholders’ equity:          
Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 and no shares outstanding at 2019 and 2018   5,610    - 
           
Common stock, par value $0.001; 300,000,000 shares authorized, 66,677,111 and 59,058,297 shares issued at 2019 and 2018, respectively   66,677    59,058 
Additional paid in capital   503,149,814    478,179,574 
Treasury stock, 4,015 shares at 2019 and 2018   (205,999)   (205,999)
Accumulated deficit   (480,228,280)   (476,721,490)
Total stockholders’ equity   22,787,822    1,311,143 
Total liabilities and stockholders’ equity  $43,305,972   $18,514,607 

 

See accompanying notes.

 

3
 

 

STEREOTAXIS, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2019   2018   2019   2018 
Revenue:                    
Systems  $1,696,964   $715,484   $1,755,015   $1,043,510 
Disposables, service and accessories   6,258,252    6,839,995    19,515,125    21,035,002 
Sublease   246,532    -    739,593    - 
Total revenue   8,201,748    7,555,479    22,009,733    22,078,512 
                     
Cost of revenue:                    
Systems   665,463    596,869    722,828    1,257,980 
Disposables, service and accessories   919,599    1,036,589    2,928,718    3,029,875 
Sublease   246,531    -    739,592    - 
Total cost of revenue   1,831,593    1,633,458    4,391,138    4,287,855 
                     
Gross margin   6,370,155    5,922,021    17,618,595    17,790,657 
                     
Operating expenses:                    
Research and development   1,751,081    2,000,780    7,405,462    5,995,800 
Sales and marketing   3,120,632    2,819,101    9,666,975    9,911,514 
General and administrative   1,539,648    1,215,920    4,186,277    3,753,703 
Total operating expenses   6,411,361    6,035,801    21,258,714    19,661,017 
Operating loss   (41,206)   (113,780)   (3,640,119)   (1,870,360)
                     
Other income   -    -    -    2,590,361 
Interest income (expense)   84,954    (2,515)   133,329    (33,271)
Net income (loss)  $43,748   $(116,295)  $(3,506,790)  $686,730 
                     
Cumulative dividend on convertible preferred stock   (360,647)   (361,447)   (1,071,351)   (1,072,553)
Loss attributable to common stockholders  $(316,899)  $(477,742)  $(4,578,141)  $(385,823)
Net loss per share attributable to common stockholders:                    
Basic  $(0.00)  $(0.01)  $(0.07)  $(0.01)
Diluted  $(0.00)  $(0.01)  $(0.07)  $(0.01)
Weighted average number of common shares and equivalents:                    
Basic   64,294,153    59,008,219    61,405,083    49,733,553 
Diluted   64,294,153    59,008,219    61,405,083    49,733,553 

 

See accompanying notes.

 

4
 

 

STEREOTAXIS, INC

STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(Unaudited)

 

Three Months Ended September 30, 2018

 

  

Convertible
Preferred Stock
(Mezzanine)

  

Preferred Stock
Series B

   Common Stock  

Additional
Paid-In

   Treasury   Accumulated  

Total
Stockholders’
Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
Beginning Balance   23,900   $5,960,475        -   $     -    58,933,384   $58,933   $477,910,692   $(205,999)  $(476,035,222)  $1,728,404 
Issuance of common stock                        666    1                   1 
Share-based compensation                       88,444    88    145,461              145,549 
Components of net loss                                           (116,295)   (116,295)
Employee stock purchase plan                       21,670    22    15,797              15,819 
Ending Balance   23,900   $5,960,475    -   $-    59,044,164   $59,044   $478,071,950   $(205,999)  $(476,151,517)  $1,773,478 

 

Three Months Ended September 30, 2019

 

  

Convertible
Preferred Stock
(Mezzanine)

  

Preferred Stock
Series B

   Common Stock  

Additional
Paid-In

   Treasury   Accumulated  

Total
Stockholders’
Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
                                         
Beginning Balance   23,855   $5,948,953    -   $   -    59,383,038   $59,383   $479,127,279   $(205,999)  $(480,272,028)  $(1,291,365)
Issuance of common stock                        7,117,276    7,117    12,928,623              12,935,740 
Share-based compensation                       32,500    33    425,680              425,713 
Components of net income                                           43,748    43,748 
Employee stock purchase plan                       8,307    8    22,836              22,844 
Preferred stock issuance             5,610,121    5,610              10,626,328              10,631,938 
Preferred stock conversion   (75)   (19,204)             135,990    136    19,068              19,204 
Ending Balance   23,780   $5,929,749    5,610,121   $5,610    66,677,111   $66,677   $503,149,814   $(205,999)  $(480,228,280)  $22,787,822 

 

See accompanying notes.

 

5
 

 

STEREOTAXIS, INC

STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(Unaudited)

 

Nine Months Ended September 30, 2018

 

  

Convertible
Preferred Stock
(Mezzanine)

  

Preferred Stock
Series B

   Common Stock  

Additional
Paid-In

   Treasury   Accumulated  

Total
Stockholders’
Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
Beginning Balance   23,900   $5,960,475       -   $    -    22,805,731   $22,806   $450,748,403   $(205,999)  $(477,132,808)  $(26,567,598)
Issuance of common stock and warrants                       35,792,593    35,793    26,813,524              26,849,317 
Share-based compensation                       382,356    382    465,611              465,993 
Components of net income                                           686,730    686,730 
Employee stock purchase plan                       63,484    63    44,412              44,475 
Cumulative catchup for adoption of ASC 606 (1)                                           294,561    294,561 
Ending Balance   23,900   $5,960,475    -   $-    59,044,164   $59,044   $478,071,950   $(205,999)  $(476,151,517)  $1,773,478 

 

Nine Months Ended September 30, 2019

 

  

Convertible
Preferred Stock
(Mezzanine)

  

Preferred Stock
Series B

   Common Stock  

Additional
Paid-In

   Treasury   Accumulated  

Total
Stockholders’
Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Stock   Deficit   (Deficit) 
                                         
Beginning Balance   23,900   $5,960,475    -   $-    59,058,297   $59,058   $478,179,574   $(205,999)  $(476,721,490)  $1,311,143 
Issuance of common stock                        7,163,760    7,164    12,878,144              12,885,308 
Share-based compensation                       206,962    207    1,380,488              1,380,695 
Components of net loss                                           (3,506,790)   (3,506,790)
Employee stock purchase plan                       32,064    32    54,770              54,802 
Preferred stock issuance             5,610,121    5,610              10,626,328              10,631,938 
Preferred stock conversion   (120)   (30,726)             216,028    216    30,510              30,726 
Ending Balance   23,780   $5,929,749    5,610,121   $5,610    66,677,111   $66,677   $503,149,814   $(205,999)  $(480,228,280)  $22,787,822 

 

(1) Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details.

 

See accompanying notes.

 

6
 

 

STEREOTAXIS, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Nine Months Ended September 30, 
   2019   2018 
Cash flows from operating activities          
Net income (loss)  $(3,506,790)  $686,730 
Adjustments to reconcile net income (loss) to cash used in operating activities:          
Depreciation   88,774    394,154 
Amortization of intangibles   -    49,491 
Amortization of deferred finance costs   -    24,657 
Non-cash lease expense   1,756,757    - 
Share-based compensation   898,836    465,851 
Loss on asset disposal   -    1,449 
Adjustment of warrants   -    (2,590,361)
Changes in operating assets and liabilities:          
Accounts receivable   1,190,716    (800,856)
Inventories   (355,050)   (55,486)
Prepaid expenses and other current assets   (58,622)   (131,116)
Other assets   (15,677)   (1,799)
Accounts payable   (694,385)   (80,066)
Accrued liabilities   480,632    (372,289)
Deferred revenue   (388,396)   553,937 
Operating lease liability   (1,718,010)   - 
Other liabilities   (380,514)   86,204 
Net cash used in operating activities   (2,701,729)   (1,769,500)
Cash flows from investing activities          
Purchase of fixed assets   (15,832)   (255,554)
Net cash used in investing activities   (15,832)   (255,554)
Cash flows from financing activities          
Proceeds from issuance of stock, net of issuance costs   23,572,048    44,621 
Proceeds from warrant exercise   -    9,864,697 
Net cash provided by financing activities   23,572,048    9,909,318 
Net increase in cash and cash equivalents   20,854,487    7,884,264 
Cash and cash equivalents at beginning of period   10,796,072    3,686,302 
Cash and cash equivalents at end of period  $31,650,559   $11,570,566 

 

See accompanying notes.

 

7
 

 

STEREOTAXIS, INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

Notes to Financial Statements

 

In this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and “our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Genesis RMN®, Epoch®, Niobe®, Odyssey®, Odyssey Cinema™, Vdrive®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™, V-CAS Deflect™, QuikCAS™, and Cardiodrive® are trademarks of Stereotaxis, Inc. All other trademarks that appear in this report are the property of their respective owners.

 

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the Genesis RMN® (Robotic Magnetic Navigation) System (“Genesis System”), the Niobe ES Robotic Magnetic Navigation System (“Niobe ES System”), Odyssey Information Management Solution (“Odyssey Solution”), the Vdrive Robotic Navigation System (“Vdrive System”), Stereotaxis Imaging Model S X-ray System, and related devices.

 

The Genesis and Niobe Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of September 30, 2019, the Company had an installed base of 125 Niobe ES Systems.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

Our Vdrive System provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive System complements the robotic magnetic navigation systems’ control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive System and the Vdrive Duo System. In addition to the Vdrive System and the Vdrive Duo System, we also manufacture and market various disposable components which can be manipulated by these systems.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

The Niobe System, Odyssey Workstation, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. The Genesis System and the V-CAS Deflect catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S System is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the nine month period ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

8
 

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented 8% and 5% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 33% of revenue for the nine months ended September 30, 2019 and 2018.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 10% of revenue for the nine months ended September 30, 2019 and 2018.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 46% and 52% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

9
 

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning in 2019. Sublease revenue represented 3% of revenue for the nine months ended September 30, 2019.

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2019   2018   2019   2018 
Systems  $1,696,964   $715,484   $1,755,015   $1,043,510 
Disposables, service and accessories   6,258,252    6,839,995    19,515,125    21,035,002 
Sublease   246,532    -    739,593    - 
Total revenue  $8,201,748   $7,555,479   $22,009,733   $22,078,512 

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $1.0 million as of September 30, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

   September 30, 2019   December 31, 2018 
Contract Assets - Unbilled Receivables  $314,494   $251,867 
           
Customer deposits   41,860    487,086 
Product shipped, revenue deferred   645,199    645,199 
Deferred service and license fees   5,157,232    5,100,402 
Total deferred revenue   5,844,291    6,232,687 
Less: Long-term deferred revenue   (560,508)   (407,151)
Total current deferred revenue  $5,283,783   $5,825,536 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the nine months ended September 30, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $5.4 million and $5.1 million respectively.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

10
 

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

   Three Months Ended September 30,   Nine Months Ended September 30, 
   2019   2018   2019   2018 
Net income (loss)  $43,748   $(116,295)  $(3,506,790)  $686,730 
Cumulative dividend on convertible preferred stock   (360,647)   (361,447)   (1,071,351)   (1,072,553)
Net loss attributable to common stockholders  $(316,899)  $(477,742)  $(4,578,141)  $(385,823)
                     
Weighted average number of common shares and equivalents:   64,294,153    59,008,219    61,405,083    49,733,553 
Basic EPS  $(0.00)  $(0.01)  $(0.07)  $(0.01)
Diluted EPS  $(0.00)  $(0.01)  $(0.07)  $(0.01)

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common because all such securities are anti-dilutive for all periods presented. The Company had no unearned restricted shares during any period.

 

As of September 30, 2019, the Company had 1,944,256 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.13 per share, 584,616 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,175,861 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock, 5,610,121 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock and accumulated dividends, and 844,087 shares of unvested restricted share units.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease revenue and the related cost as Sublease cost of revenue. See Note 6 for additional details.

 

11
 

 

3. Inventories

 

Inventories consist of the following:

 

   September 30, 2019   December 31, 2018 
Raw materials  $2,831,977   $2,686,870 
Work in process   275,745    2,594 
Finished goods   2,308,165    2,963,013 
Reserve for obsolescence   (3,869,171)   (4,460,811)
Total inventory  $1,546,716   $1,191,666 

 

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

 

   September 30, 2019   December 31, 2018 
Prepaid expenses  $500,537   $401,972 
Prepaid commissions   331,523    304,585 
Deposits   404,304    455,508 
Total prepaid expenses and other assets   1,236,364    1,162,065 
Less: Noncurrent prepaid expenses and other assets   (214,042)   (198,365)
Total current prepaid expenses and other assets  $1,022,322   $963,700 

 

5. Property and Equipment

 

   September 30, 2019   December 31, 2018 
Equipment  $6,389,366   $6,739,939 
Leasehold improvements   2,488,505    2,684,065 
    8,877,871    9,424,004 
Less: Accumulated depreciation   (8,607,120)   (9,080,311)
Net property and equipment  $270,751   $343,693 

 

Certain prior year amounts have been reclassified to conform to the 2019 presentation.

 

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (“ASC 842”) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.

 

12
 

 

The Company leases its facilities under operating leases, which were previously not recognized on the Company’s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At September 30, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.25 years.

 

The following table represents lease costs and other lease information.

 

   Three Months Ended   Nine Months Ended 
   September 30, 2019   September 30, 2019 
Operating lease cost  $585,588   $1,756,759 
Short-term lease cost   19,671    58,311 
Sublease income   (246,532)   (739,593)
Total lease cost  $358,727   $1,075,477 
           
Cash paid within operating cash flows  $612,533   $1,840,023 

 

The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019, excluding sublease income, were as follows:

 

   September 30, 2019 
2019  $572,612 
2020   2,339,810 
2021   2,382,662 
2022 and thereafter   - 
Total lease payments  $5,295,084 
Less: Interest   (485,150)
Present value of lease liabilities  $4,809,934 

 

The undiscounted future cash flows to be received under the sublease are $0.2 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.

 

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   September 30, 2019   December 31, 2018 
Accrued salaries, bonus, and benefits  $1,481,466   $1,491,844 
Accrued licenses and maintenance fees   483,879    577,389 
Accrued warranties   146,468    149,464 
Accrued taxes   204,679    192,268 
Accrued professional services   216,938    489,017 
Other   368,771    383,960 
Total accrued liabilities   2,902,201    3,283,942 
Less: Long term accrued liabilities   (260,947)   (641,461)
Total current accrued liabilities  $2,641,254   $2,642,481 

 

Certain prior year amounts have been reclassified to conform to the 2019 presentation.

 

13
 

 

8. Long-Term Debt and Credit Facilities

 

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matures on June 30, 2020. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $5.0 million subject to the value of collateralized assets and the interest rate is equal to the prime rate subject to a floor of 4.5%. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

On June 27, 2019, the Company entered into a Second Amendment to and Reinstatement of Third Amended and Restated Loan and Security Agreement with Silicon Valley Bank to extend the maturity of the revolving line of credit to June 30, 2020 under substantially identical terms to the prior agreement.

 

As of September 30, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of September 30, 2019, the Company had a borrowing capacity of $2.4 million based on the Company’s collateralized assets. The Company’s total liquidity as of September 30, 2019, was $34.1 million which included cash and cash equivalents of $31.7 million.

 

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of September 30, 2019.

 

2019 Equity Financing and Series B Convertible Preferred Stock

 

On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, in a private placement, agreed to issue and sell to the investors an aggregate of 6,585,000 shares of the Company’s common stock, $0.001 par value per share, at a price of $2.05 per share and 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholder’s equity section of the Company’s Balance Sheet.

 

The Company received net proceeds of approximately $23.1 million, after offering expenses. The Company plans to use the funds for general corporate purposes.

 

Series A Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

14
 

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

Stock Award Plans

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At September 30, 2019, the Company had 3,203,531 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At September 30, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $1.7 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the nine month period ended September 30, 2019 is as follows:

 

   Number of Options/SARs   Range of Exercise Price  Weighted Average Exercise Price per Share 
            
Outstanding, December 31, 2018   1,165,086   $0.74 - $43.90  $2.54 
Granted   992,000   $2.03 - $2.89  $2.04 
Exercised   (35,328)  $0.74 - $2.15  $0.90 
Forfeited   (177,502)  $0.74 - $43.90  $4.50 
Outstanding, September 30, 2019   1,944,256   $0.74 - $36.20  $2.13 

 

A summary of the restricted stock unit activity for the nine month period ended September 30, 2019 is as follows:

 

   Number of
Restricted Stock
Units
   Weighted Average
Grant Date Fair
Value per Unit
 
         
Outstanding, December 31, 2018   647,649   $0.83 
Granted   420,000   $1.98 
Vested   (206,962)  $1.36 
Forfeited   (16,600)  $0.76 
Outstanding, September 30, 2019   844,087   $1.28 

 

15
 

 

10. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

   September 30, 2019   December 31, 2018 
Warranty accrual, beginning of the fiscal period  $149,464   $164,365 
Accrual adjustment for product warranty   41,023    34,253 
Payments made   (44,019)   (49,154)
Warranty accrual, end of the fiscal period  $146,468   $149,464 

 

11. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

 

12. Subsequent Events

 

None.

 

16
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2018. Operating results are not necessarily indicative of results that may occur in future periods.

 

This report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in “Item 1A. Risk Factors.” Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include, but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry, economic conditions, financial condition, liquidity, capital resources, and results of operations. Such statements include, but are not limited to, statements preceded by, followed by, or that otherwise include the words “believe”, “expects”, “anticipates”, “intends”, “estimates”, “projects”, “can”, “could”, “may”, “would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking statements, which speak only as of the date on which they are made. They give our expectations regarding the future, but are not guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

 

Overview

 

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital’s interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Our capital products include the Genesis System, the Niobe System, Odyssey Solution, the Vdrive System, and the Stereotaxis Imaging Model S X-ray System. We believe that the robotic magnetic navigation systems represent a revolutionary technology in the interventional surgical suite, or “interventional lab,” and have the potential to become the standard of care for a broad range of complex cardiology procedures. We also believe that our technology represents an important advance in the ongoing trend toward digital instrumentation in the interventional lab and provides substantial, clinically important improvements, and cost efficiencies over manual interventional methods, which require years of physician training and often result in long and unpredictable procedure times and sub-optimal therapeutic outcomes.

 

The Genesis System is the latest generation of the robotic magnetic navigation system. This system is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, efficient procedures and reduced x-ray exposure. The Genesis System is CE marked and will become available in other global geographies subject to regulatory approval. The core components of the Niobe System have received regulatory clearance in the U.S., Canada, Europe, China, Japan, and various other countries. As of September 30, 2019, the Company had an installed base of 125 Niobe ES Systems.

 

17
 

 

Stereotaxis also has developed the Odyssey Solution which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution delivering synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training. The Odyssey Solution may be acquired in conjunction with a robotic magnetic navigation system or on a stand-alone basis for installation in interventional labs and other locations where clinicians often desire the benefits of the Odyssey Solution that we believe can improve clinical workflows and related efficiencies.

 

Our Vdrive System provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive System complements the robotic magnetic navigation system’s control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive System and the Vdrive Duo System. In addition to the Vdrive System and the Vdrive Duo System, we also manufacture and market various disposable components (V-Loop, V-Sono, V-CAS, and V-CAS Deflect) which can be manipulated by these systems.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. We review our estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2018.

 

Revenue Recognition

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018. We generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year warranty; warranty costs were not material for the periods presented.

 

18
 

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by a warranty that provides for the return of defective products. Warranty costs were not material for the periods presented.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed.

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. See Note 2 for additional detail on deferred revenue. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets in the Company’s balance sheets were $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Leases

 

On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company determines if a contract contains a lease at inception. For contracts where the Company is the lessee, operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liability on the Company’s balance sheet. The Company currently does not have any finance leases.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company’s leases generally do not provide an implicit rate. Lease terms may include options to extend or terminate when the Company is reasonably certain that the option will be exercised. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company’s operating leases. Additionally, the Company applies the short-term lease measurement and recognition exemption in which right of use assets and lease liabilities are not recognized for leases less than twelve months.

 

Cost of Contracts

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Results of Operations

 

Comparison of the Three Months Ended September 30, 2019 and 2018

 

Revenue. Revenue increased from $7.6 million for the three months ended September 30, 2018 to $8.2 million for the three months ended September 30, 2019, an increase of 9%. Revenue from the sale of systems increased from $0.7 million to $1.7 million, for the three months ended September 30, 2019, an increase of approximately 137%. We recognized revenue on one Niobe ES System and a total of $0.7 million for Odyssey Systems during the 2019 period. Revenue for the prior period included $0.7 million for Odyssey Systems. Revenue from sales of disposable interventional devices, service, and accessories decreased to $6.3 million for the three months ended September 30, 2019 from $6.8 million for the three months ended September 30, 2018, a decrease of approximately 9% due to decreased service revenue. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.2 million of sublease income as revenue for the three months ended September 30, 2019.

 

19
 

 

Cost of Revenue. Cost of revenue increased from $1.6 million for the three months ended September 30, 2018 to $1.8 million for the three months ended September 30, 2019, an increase of approximately 12%. As a percentage of our total revenue, overall gross margin in the current year period benefited from the reduction of prior year inventory-related charges and remained consistent with the overall gross margin in the prior year period of 78%. Excluding the impact of the new lease guidance, gross margin for the three months ended September 30, 2019 was 80%. Cost of revenue for systems sold increased from $0.6 million for the three months ended September 30, 2018 to $0.7 million for the three months ended September 30, 2019 due to direct charges in the current year period. Gross margin for systems was $0.1 million for the three months ended September 30, 2018 compared to $1.0 million for the three months ended September 30, 2019. This increase was primarily due to improved system sales volumes. Cost of revenue for disposables, service, and accessories decreased to $0.9 million for the three months ended September 30, 2019 from $1.0 million for the three months ended September 30, 2018 due to lower expenses incurred under service contracts in the current year period. Gross margin for disposables, service, and accessories remained relatively consistent at 85% for the three months ended September 30, 2019 and September 30, 2018. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.2 million of cost of sublease for the three months ended September 30, 2019.

 

Research and Development Expenses. Research and development expenses decreased from $2.0 million for the three months ended September 30, 2018 to $1.8 million for the three months ended September 30, 2019, a decrease of approximately 12%. This decrease was primarily due to lower spending for new projects in the three months ending September 30, 2019.
 

Sales and Marketing Expenses. Sales and marketing expenses increased from $2.8 million for the three months ended September 30, 2018 to $3.1 million for the three months ended September 30, 2019, an increase of approximately 11%. This increase was primarily due to higher commission costs.

 

General and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management. General and administrative expenses increased from $1.2 million for the three months ended September 30, 2018 to $1.5 million for the three months ended September 30, 2019, an increase of approximately 27%. This increase was primarily due to increased professional fees.

 

Interest Income (Expense). Interest income for the three months ended September 30, 2019 was less than $0.1 million compared to interest expense of less than $0.1 million for the three months ended September 30, 2018.

 

Comparison of the Nine Months Ended September 30, 2019 and 2018

 

Revenue. Revenue decreased from $22.1 million for the nine months ended September 30, 2018 to $22.0 million for the nine months ended September 30, 2019, a decrease of less than 1%. Revenue from the sale of systems increased from $1.0 million to $1.8 million, an increase of approximately 68%. We recognized revenue on one Niobe ES System and a total of $0.7 million for Odyssey Systems during the 2019 period. Revenue for the prior period included $1.0 million for Odyssey and Odyssey Cinema Systems. Revenue from sales of disposable interventional devices, service and accessories decreased to $19.5 million for the nine months ended September 30, 2019 from $21.0 million for the nine months ended September 30, 2018, a decrease of approximately 7% primarily due to decreased service revenue. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.7 million of sublease income as revenue for the nine months ended September 30, 2019.

 

Cost of Revenue. Cost of revenue increased from $4.3 million for the nine months ended September 30, 2018 to $4.4 million for the nine months ended September 30, 2019, an increase of approximately 2%. As a percentage of our total revenue, overall gross margin decreased to 80% for the nine months ended September 30, 2019 from 81% for the nine months ended September 30, 2018. Excluding the impact of the new lease guidance, gross margin for the nine months ended September 30, 2019 was 83%. Cost of revenue for systems sold decreased from $1.3 million for the nine months ended September 30, 2018 to $0.7 million for the nine months ended September 30, 2019, a decrease of approximately 43%, primarily due to decreased product costs and reductions in prior period inventory related charges. Gross margin for systems increased from negative $0.2 million for the nine months ended September 30, 2018 to $1.0 million for the nine months ended September 30, 2019. Cost of revenue for disposables, service, and accessories decreased to $2.9 million for the nine months ended September 30, 2019 from $3.0 million for the nine months ended September 30, 2018 due to lower expenses incurred under service contracts in the current year period. Gross margin for disposables, service and accessories was 85% for the current period compared to 86% for the nine months ended September 30, 2018 driven by decreased service revenue from contract billings in the current year period. The adoption of new lease accounting guidance as of January 1, 2019 required the Company to record $0.7 million of cost of sublease for the nine months ended September 30, 2019.

 

Research and Development Expenses. Research and development expenses increased from $6.0 million for the nine months ended September 30, 2018 to $7.4 million for the nine months ended September 30, 2019, an increase of approximately 24%. This increase was due to higher project-based expenses.

 

Sales and Marketing Expenses. Sales and marketing expenses decreased from $9.9 million for the nine months ended September 30, 2018 to $9.7 million for the nine months ended September 30, 2019, a decrease of approximately 2%. This decrease was primarily due to a more efficient distribution of clinical adoption and marketing resources favorably impacting both headcount and contractor costs.

 

20
 

 

General and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management. General and administrative expenses increased to $4.2 million for the nine months ended September 30, 2019 from $3.8 million for the nine months ended September 30, 2018, an increase of 12%. This increase was primarily driven by higher administrative costs and professional fees.

 

Other Income (Expense). Other income (expense) represents the non-cash change in market value of certain warrants classified as a derivative and recorded as a current liability under general accounting principles for determining whether an instrument (or embedded feature) is indexed to an entity’s own stock.

 

Interest Income (Expense). Interest income for the nine months ended September 30, 2019 was $0.1 million compared to interest expense of less than $0.1 million for the nine months ended September 30, 2018.

 

Liquidity and Capital Resources

 

Liquidity refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial assets consist of cash and cash equivalents. At September 30, 2019 we had $31.7 million of cash and equivalents. We had working capital of $26.9 million as of September 30, 2019 compared to approximately $7.8 million as of December 31, 2018. The increase in working capital was primarily driven by the net proceeds from the August Securities Purchase Agreement, offset by the net loss incurred during the first nine months of 2019 and adoption of the new lease accounting guidance.

 

The following table summarizes our cash flow by operating, investing and financing activities for the nine months ended September 30, 2019 and 2018 (in thousands):

 

   Nine Months Ended September 30, 
   2019   2018 
Cash flow used in operating activities  $(2,702)  $(1,770)
Cash flow used in investing activities   (16)   (256)
Cash flow provided by financing activities   23,572    9,909 

 

Net cash used in operating activities. We used approximately $2.7 million and $1.8 million of cash for operating activities during the nine months ended September 30, 2019 and 2018, respectively. The increase in cash used in operating activities was driven by larger operating losses offset by improved working capital.

 

Net cash used in investing activities. We used less than $0.1 million of cash during the nine months ended September 30, 2019 for the purchases of equipment, and approximately $0.3 million for leasehold improvements and purchases of equipment for the nine months ended September 30, 2018.

 

Net cash provided by (used in) financing activities. We generated $23.6 million of cash for the nine month period ended September 30, 2019 compared to approximately $9.9 million generated for the nine month period ended September 30, 2018. The cash generated in the nine month period ended September 30, 2019 was driven by the net proceeds from a Securities Purchase Agreement in August 2019. The cash generated in the nine months ended September 30, 2018 was primarily related to the warrant exercise in March 2018.

 

Capital Resources

 

As of September 30, 2019, our borrowing facilities were comprised of a revolving line of credit maintained with our primary lender, Silicon Valley Bank.

 

Revolving Line of Credit

 

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matures on June 30, 2020. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $5.0 million subject to the value of collateralized assets and the interest rate is equal to the prime rate subject to a floor of 4.5%. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

On June 27, 2019, the Company entered into a Second Amendment to and Reinstatement of Third Amended and Restated Loan and Security Agreement with Silicon Valley Bank to extend the maturity of the revolving line of credit to June 30, 2020 under substantially identical terms to the prior agreement.

 

21
 

 

As of September 30, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of September 30, 2019, the Company had a borrowing capacity of $2.4 million based on the Company’s collateralized assets. The Company’s total liquidity as of September 30, 2019, was $34.1 million which included cash and cash equivalents of $31.7 million.

 

Common Stock

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of September 30, 2019.

 

2019 Equity Financing

 

As disclosed in Note 9, on August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, in a private placement, agreed to issue and sell to the investors an aggregate of 6,585,000 shares of the Company’s common stock, $0.001 par value per share, at a price of $2.05 per share and 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement.

 

The Company received net proceeds of approximately $23.1 million, after offering expenses. The Company plans to use the funds for general corporate purposes.

 

2016 Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

Off-Balance Sheet Arrangements

 

We do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market, or credit risk that could have arisen if we had engaged in these relationships.

 

22
 

 

ITEM 3. [RESERVED]

 

None.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

 

Changes In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the period covered by this report.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are involved from time to time in various lawsuits and claims arising in the normal course of business. Although the outcomes of these lawsuits and claims are uncertain, we do not believe any of them will have a material adverse effect on our business, financial condition or results of operations.

 

ITEM 1A. RISK FACTORS

 

Additional Risk Factors are discussed in our Annual Report on Form 10-K for the year ended December 31, 2018.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. [RESERVED]

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Number   Description
     
3.1   Restated Articles of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.
     
3.2   Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (File No. 000-50884) filed on July 10, 2012.
     
3.3   Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on September 30, 2016.
     
3.4   Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on August 8, 2019.
     
3.5   Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.
     
10.1   Securities Purchase Agreement, dated August 7, 2019, between the Company and certain investors named therein, incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K (file No. 001-36159) filed on August 8, 2019.
     
10.2   Registration Rights Agreement, dated August 7, 2019, between the Company and certain investors named therein, incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K (file No. 001-36159) filed on August 8, 2019.
     
31.1   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
31.2   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
32.1   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
32.2   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
101.INS   XBRL Instance Document.
     
101.SCH   XBRL Taxonomy Extension Schema Document.
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.

 

23
 

 

STEREOTAXIS, INC.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

STEREOTAXIS, INC.
(Registrant)

     
Date: November 14, 2019 By: /S/ David L. Fischel
   

David L. Fischel
Chief Executive Officer

     
Date: November 14, 2019 By: /S/ Kimberly R. Peery
   

Kimberly R. Peery
Chief Financial Officer

 

24
 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification of Principal Executive Officer

 

I, David L. Fischel, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2019 /S/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.
  (Principal Executive Officer)

 

 
 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification of Principal Financial Officer

 

I, Kimberly R. Peery, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;
     
  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
     
  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2019 /s/ Kimberly R. Peery
  Kimberly R. Peery
  Chief Financial Officer
  Stereotaxis, Inc.
  (Principal Financial Officer)

 

 
 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Fischel, Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2019 /S/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.

 

 
 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly R. Peery, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 14, 2019 /s/ Kimberly R. Peery
  Kimberly R. Peery
  Chief Financial Officer
  Stereotaxis, Inc.

 

 
 

EX-101.INS 6 stxs-20190930.xml XBRL INSTANCE FILE 0001289340 2019-01-01 2019-09-30 0001289340 2019-09-30 0001289340 2017-12-31 0001289340 STXS:SystemsMember 2019-01-01 2019-09-30 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2019-01-01 2019-09-30 0001289340 STXS:SystemsMember 2018-01-01 2018-09-30 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2018-01-01 2018-09-30 0001289340 STXS:ContractAssetsUnbilledReceivablesMember 2019-09-30 0001289340 STXS:ContractAssetsUnbilledReceivablesMember 2018-12-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2019-09-30 0001289340 STXS:ProductShippedRevenueDeferredMember 2018-12-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2019-09-30 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2018-12-31 0001289340 us-gaap:EquipmentMember 2019-09-30 0001289340 us-gaap:EquipmentMember 2018-12-31 0001289340 us-gaap:LeaseholdImprovementsMember 2019-09-30 0001289340 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001289340 us-gaap:RevolvingCreditFacilityMember 2019-09-30 0001289340 STXS:RangeOneMember 2019-01-01 2019-09-30 0001289340 STXS:RangeTwoMember 2019-01-01 2019-09-30 0001289340 STXS:RangeThreeMember 2019-01-01 2019-09-30 0001289340 STXS:RangeFourMember 2019-01-01 2019-09-30 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2014-06-09 2014-06-10 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001289340 srt:MinimumMember 2018-03-05 0001289340 srt:MaximumMember 2018-03-05 0001289340 STXS:RangeFiveMember 2019-01-01 2019-09-30 0001289340 2018-09-30 0001289340 us-gaap:CommonStockMember 2017-12-31 0001289340 us-gaap:CommonStockMember 2018-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001289340 us-gaap:TreasuryStockMember 2017-12-31 0001289340 us-gaap:TreasuryStockMember 2018-12-31 0001289340 us-gaap:RetainedEarningsMember 2017-12-31 0001289340 us-gaap:RetainedEarningsMember 2018-12-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2017-12-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-12-31 0001289340 STXS:CustomerDepositsMember 2019-09-30 0001289340 STXS:CustomerDepositsMember 2018-12-31 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-01 2016-09-30 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-30 0001289340 us-gaap:WarrantMember 2018-03-01 2018-03-05 0001289340 2018-12-31 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-01-01 2018-09-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-09-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-09-30 0001289340 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001289340 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001289340 us-gaap:CommonStockMember 2018-09-30 0001289340 us-gaap:CommonStockMember 2019-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001289340 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001289340 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0001289340 us-gaap:TreasuryStockMember 2018-09-30 0001289340 us-gaap:TreasuryStockMember 2019-09-30 0001289340 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001289340 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001289340 us-gaap:RetainedEarningsMember 2018-09-30 0001289340 us-gaap:RetainedEarningsMember 2019-09-30 0001289340 2018-06-30 0001289340 2018-01-01 2018-09-30 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2019-01-01 2019-09-30 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2018-01-01 2018-09-30 0001289340 STXS:DisposableRevenueMember 2019-01-01 2019-09-30 0001289340 STXS:DisposableRevenueMember 2018-01-01 2018-09-30 0001289340 STXS:RoyaltyRevenueMember 2019-01-01 2019-09-30 0001289340 STXS:RoyaltyRevenueMember 2018-01-01 2018-09-30 0001289340 STXS:OtherRecurringRevenueMember 2019-01-01 2019-09-30 0001289340 STXS:OtherRecurringRevenueMember 2018-01-01 2018-09-30 0001289340 STXS:SubleaseRevenueMember 2019-01-01 2019-09-30 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0001289340 2018-07-01 2018-09-30 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2013-06-03 2013-06-05 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2016-05-22 2016-05-24 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2017-05-21 2017-05-23 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0001289340 2018-01-01 2018-12-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2019-09-30 0001289340 us-gaap:WarrantMember 2019-09-30 0001289340 us-gaap:RevolvingCreditFacilityMember STXS:PrimaryLenderMember 2019-09-30 0001289340 us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember STXS:PrimaryLenderMember 2019-01-01 2019-09-30 0001289340 STXS:SystemsMember 2019-07-01 2019-09-30 0001289340 STXS:SystemsMember 2018-07-01 2018-09-30 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2019-07-01 2019-09-30 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2018-07-01 2018-09-30 0001289340 2019-07-01 2019-09-30 0001289340 2019-06-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-07-01 2019-09-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-07-01 2018-09-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2019-06-30 0001289340 us-gaap:ConvertiblePreferredStockMember 2018-06-30 0001289340 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001289340 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001289340 us-gaap:CommonStockMember 2019-06-30 0001289340 us-gaap:CommonStockMember 2018-06-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001289340 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001289340 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001289340 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001289340 us-gaap:TreasuryStockMember 2019-06-30 0001289340 us-gaap:TreasuryStockMember 2018-06-30 0001289340 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001289340 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001289340 us-gaap:RetainedEarningsMember 2019-06-30 0001289340 us-gaap:RetainedEarningsMember 2018-06-30 0001289340 2019-10-31 0001289340 us-gaap:SeriesBPreferredStockMember 2018-12-31 0001289340 us-gaap:SeriesBPreferredStockMember 2019-09-30 0001289340 us-gaap:SeriesBPreferredStockMember 2019-07-01 2019-09-30 0001289340 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-09-30 0001289340 us-gaap:SeriesBPreferredStockMember 2017-12-31 0001289340 us-gaap:SeriesBPreferredStockMember 2018-06-30 0001289340 us-gaap:SeriesBPreferredStockMember 2019-06-30 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2019-01-01 2019-09-30 0001289340 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001289340 STXS:SeriesBConvertiblePreferredStockMember 2019-01-01 2019-09-30 0001289340 us-gaap:AccountingStandardsUpdate201602Member 2019-01-02 0001289340 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2019-08-06 2019-08-07 0001289340 us-gaap:PrivatePlacementMember STXS:SeriesBConvertiblePreferredStockMember 2019-08-06 2019-08-07 0001289340 us-gaap:PrivatePlacementMember 2019-08-06 2019-08-07 0001289340 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2019-08-07 0001289340 us-gaap:PrivatePlacementMember STXS:SeriesBConvertiblePreferredStockMember 2019-08-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure STXS:Integer Stereotaxis, Inc. 0001289340 10-Q 2019-09-30 false --12-31 Non-accelerated Filer Q3 2019 368191 398847 0.001 1000 0.001 0.001 0.001 0.001 0.001 300000000 300000000 66677111 59058297 4015 4015 3830395 5021111 31650559 10796072 1546716 1191666 1022322 963700 38049992 17972549 270751 343693 214042 198365 43305972 18514607 2641254 2642481 1031975 1726360 66677 59058 43305972 18514607 22787822 -26567598 1773478 22806 59058 450748403 478179574 -205999 -205999 -477132808 -476721490 5960475 5960475 1311143 5960475 5929749 59044 66677 478071950 503149814 -205999 -205999 -476151517 -480228280 1728404 -1291365 5948953 5960475 59383 58933 479127279 477910692 -205999 -205999 -480272028 -476035222 5610 -480228280 -476721490 205999 205999 503149814 478179574 11192477 10194377 260947 641461 14588401 11242989 4391138 722828 2928718 1257980 3029875 4287855 1633458 665463 596869 919599 1036589 1831593 17618595 17790657 5922021 6370155 -3640119 -1870360 -113780 -41206 21258714 19661017 6035801 6411361 4186277 3753703 1215920 1539648 9666975 9911514 2819101 3120632 7405462 5995800 2000780 1751081 -3506790 686730 -3506790 686730 -116295 43748 43748 -116295 -4578141 -385823 -477742 -316899 -0.07 -0.01 -0.01 -0.00 -0.07 -0.01 -0.01 -0.00 61405083 49733553 59008219 64294153 61405083 49733553 59008219 64294153 -2701729 -1769500 -380514 86204 480632 -372289 -694385 -80066 15677 1799 58622 131116 355050 55486 -1190716 800856 2590361 898836 465851 24657 49491 88774 394154 -15832 -255554 15832 255554 20854487 7884264 23572048 9909318 23572048 44621 10000000 9864697 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b><i>1. Description of Business</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Stereotaxis designs, manufactures and markets an advanced robotic navigation system for use in a hospital&#8217;s interventional surgical suite, or &#8220;interventional lab&#8221;, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the Genesis RMN<sup>&#174;</sup> (Robotic Magnetic Navigation) System (&#8220;Genesis System&#8221;), the <i>Niobe</i> ES Robotic Magnetic Navigation System (&#8220;<i>Niobe </i>ES System&#8221;), <i>Odyssey</i> Information Management Solution (&#8220;<i>Odyssey </i>Solution&#8221;), the <i>Vdrive</i> Robotic Navigation System (&#8220;<i>Vdrive</i> System&#8221;), Stereotaxis Imaging Model S X-ray System, and related devices.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The <i>Genesis </i>and <i>Niobe</i> Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of September 30, 2019, the Company had an installed base of 125 <i>Niobe </i>ES Systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the <i>Odyssey</i> Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called <i>Odyssey Cinema</i>, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global <i>Odyssey</i> Network providing physicians with a tool for clinical collaboration, remote consultation, and training.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Our <i>Vdrive</i> System provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The <i>Vdrive</i> System complements the robotic magnetic navigation systems&#8217; control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the <i>Vdrive</i> System and the <i>Vdrive Duo</i> System. In addition to the <i>Vdrive</i> System and the <i>Vdrive Duo</i> System, we also manufacture and market various disposable components which can be manipulated by these systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The <i>Niobe</i> System<i>, Odyssey Workstation, Cardiodrive,</i> and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the <i>Vdrive</i> and <i>Vdrive Duo</i> Systems with the <i>V-CAS</i>, <i>V-Loop </i>and <i>V-Sono</i> devices in the U.S., Canada and Europe. The <i>Genesis </i>System and the <i>V-CAS Deflect</i> catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S System is CE marked and FDA cleared.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>2. Summary of Significant Accounting Policies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Basis of Presentation </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the nine month period ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Financial Instruments </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (&#8220;Level 1&#8221;) and the lowest priority to unobservable inputs (&#8220;Level 3&#8221;).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Revenue and Costs of Revenue </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company adopted Accounting Standards Codification Topic 606 (&#8220;ASC 606&#8221;), <i>Revenue from Contracts with Customers</i>, on January 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Systems:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company&#8217;s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented 8% and 5% of revenue for the nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Disposables:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 33% of revenue for the nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Royalty:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 10% of revenue for the nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Other Recurring Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 46% and 52% of revenue for the nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Sublease Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning in 2019. Sublease revenue represented 3% of revenue for the nine months ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%"><font style="font-size: 10pt">Systems</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,696,964</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">715,484</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,755,015</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,043,510</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,258,252</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,839,995</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">19,515,125</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">21,035,002</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Sublease</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">246,532</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">739,593</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">8,201,748</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">7,555,479</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,009,733</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">22,078,512</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company&#8217;s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $1.0 million as of September 30, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Contract Assets - Unbilled Receivables</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">314,494</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">41,860</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Deferred service and license fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,157,232</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,100,402</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5,844,291</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less: Long-term deferred revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(560,508</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(407,151</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font-size: 10pt">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,283,783</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Revenue recognized for the nine months ended September 30, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $5.4 million and $5.1 million respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Assets Recognized from the Costs to Obtain a Contract with a Customer</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company has determined that sales incentive programs for the Company&#8217;s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company&#8217;s balance sheet was $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Share-Based Compensation </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Net Income (Loss) per Common Share (&#8220;EPS&#8221;)</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the &#8220;control number&#8221; in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">43,748</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(116,295</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(3,506,790</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">686,730</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(360,647</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(361,447</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,071,351</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,072,553</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net loss attributable to common stockholders</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(316,899</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(477,742</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,578,141</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(385,823</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">64,294,153</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,008,219</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">61,405,083</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">49,733,553</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common because all such securities are anti-dilutive for all periods presented. <font style="background-color: white">The Company had no unearned restricted shares during any period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">As of September 30, 2019, the Company had 1,944,256 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.13 per share, 584,616 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,175,861 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock, 5,610,121 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock and accumulated dividends, and 844,087 shares of unvested restricted share units.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2016-02, <i>Leases (Topic 842)</i>, and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (&#8220;ASC 842&#8221;) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease revenue and the related cost as Sublease cost of revenue. See Note 6 for additional details.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Basis of Presentation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the nine month period ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Financial Instruments</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (&#8220;Level 1&#8221;) and the lowest priority to unobservable inputs (&#8220;Level 3&#8221;).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Share-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Net Income (Loss) per Common Share (&#8220;EPS&#8221;)</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the &#8220;control number&#8221; in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">43,748</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(116,295</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(3,506,790</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">686,730</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(360,647</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(361,447</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,071,351</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,072,553</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net loss attributable to common stockholders</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(316,899</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(477,742</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,578,141</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(385,823</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">64,294,153</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,008,219</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">61,405,083</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">49,733,553</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common because all such securities are anti-dilutive for all periods presented. <font style="background-color: white">The Company had no unearned restricted shares during any period.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">As of September 30, 2019, the Company had 1,944,256 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.13 per share, 584,616 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,175,861 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock, 5,610,121 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock and accumulated dividends, and 844,087 shares of unvested restricted share units.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2016-02,&#160;<i>Leases (Topic 842)</i>, and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (&#8220;ASC 842&#8221;) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the &#8216;package of practical expedients&#8217;, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity&#8217;s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease revenue and the related cost as Sublease cost of revenue. See Note 6 for additional details.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended September 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 41%"><font style="font: 10pt Times New Roman, Times, Serif">Systems</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,696,964</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">715,484</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,755,015</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,043,510</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,258,252</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,839,995</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,515,125</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,035,002</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sublease</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">246,532</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">739,593</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total revenue</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,201,748</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,555,479</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,009,733</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,078,512</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30,&#160;2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,&#160;2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Contract Assets - Unbilled Receivables</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">314,494</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41,860</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred service and license fees</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,157,232</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,100,402</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,844,291</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Long-term deferred revenue</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(560,508</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(407,151</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,283,783</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>3. Inventories</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">Inventories consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,831,977</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,686,870</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">275,745</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,594</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,308,165</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,963,013</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolescence</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,869,171</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,460,811</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total inventory</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,546,716</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,191,666</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">Inventories consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,831,977</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,686,870</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">275,745</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,594</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,308,165</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,963,013</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolescence</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(3,869,171</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,460,811</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total inventory</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,546,716</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,191,666</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>4. Prepaid Expenses and Other Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">Prepaid expenses and other assets consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500,537</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">401,972</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Prepaid commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">331,523</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">304,585</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">404,304</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">455,508</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total prepaid expenses and other assets</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,236,364</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,162,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Noncurrent prepaid expenses and other assets</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(214,042</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(198,365</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total current prepaid expenses and other assets</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,022,322</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">963,700</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">Prepaid expenses and other assets consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500,537</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">401,972</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Prepaid commissions</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">331,523</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">304,585</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deposits</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">404,304</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">455,508</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total prepaid expenses and other assets</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,236,364</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,162,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less: Noncurrent prepaid expenses and other assets</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(214,042</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(198,365</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total current prepaid expenses and other assets</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,022,322</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">963,700</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>5. Property and Equipment</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Equipment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,389,366</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,739,939</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,488,505</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,684,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,877,871</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,424,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated depreciation</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8,607,120</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9,080,311</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net property and equipment</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,751</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">343,693</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in">Certain prior year amounts have been reclassified to conform to the 2019 presentation.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Equipment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,389,366</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,739,939</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,488,505</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,684,065</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,877,871</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,424,004</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated depreciation</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8,607,120</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(9,080,311</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Net property and equipment</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">270,751</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">343,693</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>7. Accrued Liabilities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Accrued liabilities consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued salaries, bonus, and benefits</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,481,466</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,491,844</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued licenses and maintenance fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">483,879</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">577,389</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued warranties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146,468</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">204,679</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192,268</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued professional services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">216,938</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">489,017</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368,771</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">383,960</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,902,201</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,283,942</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Long term accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(260,947</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(641,461</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total current accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,641,254</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,642,481</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Certain prior year amounts have been reclassified to conform to the 2019 presentation.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Accrued liabilities consist of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued salaries, bonus, and benefits</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,481,466</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,491,844</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued licenses and maintenance fees</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">483,879</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">577,389</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued warranties</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146,468</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued taxes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">204,679</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">192,268</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrued professional services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">216,938</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">489,017</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368,771</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">383,960</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total accrued liabilities</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,902,201</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,283,942</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Long term accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(260,947</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(641,461</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total current accrued liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,641,254</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,642,481</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>8. Long-Term Debt and Credit Facilities</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matures on June 30, 2020. The revolving line of credit is secured by substantially all of the Company&#8217;s assets. The maximum available under the line is $5.0 million subject to the value of collateralized assets and the interest rate is equal to the prime rate subject to a floor of 4.5%. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">On June 27, 2019, the Company entered into a Second Amendment to and Reinstatement of Third Amended and Restated Loan and Security Agreement with Silicon Valley Bank to extend the maturity of the revolving line of credit to June 30, 2020 under substantially identical terms to the prior agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">As of September 30, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of September 30, 2019, the Company had a borrowing capacity of $2.4 million based on the Company&#8217;s collateralized assets. The Company&#8217;s total liquidity as of September 30, 2019, was $34.1 million which included cash and cash equivalents of $31.7 million.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>9. Convertible Preferred Stock and Stockholders&#8217; Equity</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 23.8pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>2019 Equity Financing and Series B Convertible Preferred Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, in a private placement, agreed to issue and sell to the investors an aggregate of 6,585,000 shares of the Company&#8217;s common stock, $0.001 par value per share, at a price of $2.05 per share and 5,610,121 shares of the Company&#8217;s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company&#8217;s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholder&#8217;s equity section of the Company&#8217;s Balance Sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company received net proceeds of approximately $23.1 million, after offering expenses. The Company plans to use the funds for general corporate purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white"><b><i>Series A Convertible Preferred Stock and Warrants</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company&#8217;s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder&#8217;s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company&#8217;s assets, or the sale of more than 50% of the outstanding shares of the Company&#8217;s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company&#8217;s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">The warrants issued in conjunction with the convertible preferred stock (the &#8220;SPA Warrants&#8221;) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company&#8217;s control, and were classified as liabilities under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in &#8220;Other income (expense)&#8221; in the Statements of Operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders&#8217; equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Stock Award Plans</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the &#8220;Plan&#8221;) which was subsequently approved by the Company&#8217;s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At September 30, 2019, the Company had 3,203,531 remaining shares of the Company&#8217;s common stock to provide for current and future grants under its various equity plans.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">At September 30, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company&#8217;s stock award plans but not yet recognized was approximately $1.7 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">A summary of the option and stock appreciation rights activity for the nine month period ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Options/SARs</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Range of Exercise Price</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Exercise Price per Share</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,165,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $43.90</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.54</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">992,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$2.03 - $2.89</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.04</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35,328</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $2.15</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.90</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(177,502</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $43.90</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.50</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,944,256</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $36.20</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.13</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">A summary of the restricted stock unit activity for the nine month period ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of<br /> Restricted Stock<br /> Units</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average<br /> Grant Date Fair<br /> Value per Unit</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">647,649</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.83</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">420,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.98</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(206,962</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.36</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16,600</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.76</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">844,087</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.28</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">A summary of the option and stock appreciation rights activity for the nine month period ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Options/SARs</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Range of Exercise Price</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Exercise Price per Share</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 50%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,165,086</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 13%; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $43.90</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.54</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">992,000</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$2.03 - $2.89</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.04</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(35,328</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $2.15</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.90</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(177,502</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $43.90</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.50</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,944,256</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">$0.74 - $36.20</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.13</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">A summary of the restricted stock unit activity for the nine month period ended September 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of<br /> Restricted Stock<br /> Units</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average<br /> Grant Date Fair<br /> Value per Unit</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">647,649</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.83</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">420,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.98</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(206,962</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.36</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16,600</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.76</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, September 30, 2019</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">844,087</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.28</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>10. Product Warranty Provisions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company&#8217;s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company&#8217;s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Accrued warranty, which is included in other accrued liabilities, consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Warranty accrual, beginning of the fiscal period</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">164,365</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrual adjustment for product warranty</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41,023</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34,253</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Payments made</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44,019</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(49,154</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warranty accrual, end of the fiscal period</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146,468</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Accrued warranty, which is included in other accrued liabilities, consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.3in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 60%"><font style="font: 10pt Times New Roman, Times, Serif">Warranty accrual, beginning of the fiscal period</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">164,365</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Accrual adjustment for product warranty</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41,023</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">34,253</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Payments made</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44,019</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(49,154</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warranty accrual, end of the fiscal period</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">146,468</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,464</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> true false false 5283783 5825536 2590361 -388396 553937 22805731 59058297 23900 23900 23900 23780 59044164 66677111 23855 23900 59383038 58933384 5610121 63484 32064 1 8307 21670 54802 63 32 44412 54770 44475 15819 22844 8 22 22836 15797 35792593 7163760 12885308 35793 7164 26813524 12878144 26849317 294561 294561 125 0.08 0.05 0.33 0.33 0.10 0.10 0.46 0.52 0.03 5400000 5100000 P4Y 1944256 1165086 2.13 2.54 2.13 0.70 0.28 0.70 0.70 647649 844087 560508 407151 5844291 314494 251867 645199 645199 5157232 5100402 41860 487086 6232687 2831977 2686870 275745 2594 2308165 2963013 3869171 4460811 500537 401972 331523 304585 404304 455508 1236364 1162065 214042 198365 8877871 6389366 6739939 2488505 2684065 9424004 8607120 9080311 1481466 1491844 483879 577389 146468 164365 149464 204679 192268 216938 489017 368771 383960 2902201 3283942 260947 641461 5000000 2400000 1 24000 5610121 5610121 0.001 0.65 36923078 0.06 0.50 2021-09-29 27000000 35328 1700000 P4Y 1000000 1000000 1500000 4000000 3203531 992000 177502 0.74 2.03 0.74 0.74 0.74 43.90 2.89 2.15 43.90 36.20 2.04 0.90 4.50 420000 206962 16600 0.83 1.28 1.98 1.36 0.76 1071351 1072553 361447 360647 844087 1944256 584616 43175861 5610121 P1Y 41023 34253 44019 49154 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>6. Leases</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02&#160;<i>&#8220;Leases&#8221; (Topic 842)</i>&#160;and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (&#8220;ASC 842&#8221;) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company leases its facilities under operating leases, which were previously not recognized on the Company&#8217;s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (&#8220;ROU&#8221;) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company&#8217;s lease agreements often include one or more options to renew at the Company&#8217;s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At September 30, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.25 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following table represents lease costs and other lease information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font: 10pt Times New Roman, Times, Serif">Operating lease cost</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">585,588</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,756,759</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Short-term lease cost</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,671</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58,311</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sublease income</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(246,532</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(739,593</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total lease cost</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">358,727</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,075,477</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cash paid within operating cash flows</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">612,533</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,840,023</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019, excluding sublease income, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">572,612</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,339,810</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,382,662</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">2022 and thereafter</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Total lease payments</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,295,084</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Interest</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(485,150</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Present value of lease liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,809,934</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The undiscounted future cash flows to be received under the sublease are $0.2 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>11. Commitments and Contingencies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following table sets forth the computation of basic and diluted EPS:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 32%"><font style="font-size: 10pt">Net income (loss)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">43,748</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(116,295</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">(3,506,790</font></td> <td style="width: 1%"><font style="font-size: 10pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">686,730</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cumulative dividend on convertible preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(360,647</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(361,447</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,071,351</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,072,553</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net loss attributable to common stockholders</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(316,899</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(477,742</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(4,578,141</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(385,823</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Weighted average number of common shares and equivalents:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">64,294,153</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">59,008,219</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">61,405,083</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">49,733,553</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Basic EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Diluted EPS</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.00</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.07</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">(0.01</font></td> <td><font style="font-size: 10pt">)</font></td></tr> </table> <p style="margin: 0pt"></p> 4771187 6200000 2574469 2235465 739593 246532 1380695 382 207 465611 1380488 465993 145549 425713 33 88 425680 145461 382356 206962 32500 88444 -120 216028 -75 135990 30726 -30726 216 30510 19204 -19204 136 19068 -1718010 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>12. Subsequent Events</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 11.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">None.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following table represents lease costs and other lease information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%"><font style="font: 10pt Times New Roman, Times, Serif">Operating lease cost</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">585,588</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,756,759</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Short-term lease cost</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,671</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">58,311</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sublease income</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(246,532</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(739,593</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total lease cost</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">358,727</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,075,477</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cash paid within operating cash flows</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">612,533</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,840,023</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> 22009733 1755015 19515125 1043510 21035002 22078512 7555479 1696964 715484 6258252 6839995 8201748 0.090 P2Y2M30D 4809934 1756759 585588 58311 19671 1075477 358727 1840023 612533 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Assets Recognized from the Costs to Obtain a Contract with a Customer</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company has determined that sales incentive programs for the Company&#8217;s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company&#8217;s balance sheet was $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.15in"><b><i>Revenue and Costs of Revenue</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.35in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company adopted Accounting Standards Codification Topic 606 (&#8220;ASC 606&#8221;),&#160;<i>Revenue from Contracts with Customers</i>, on January 1, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Systems:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company&#8217;s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented 8% and 5% of revenue for the nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Disposables:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 33% of revenue for the nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Royalty:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 10% of revenue for the nine months ended September 30, 2019 and 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Other Recurring Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 46% and 52% of revenue for the nine months ended September 30, 2019 and 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify"><u>Sublease Revenue:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.35in; text-align: justify">The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning in 2019. Sublease revenue represented 3% of revenue for the nine months ended September 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended September 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Nine Months Ended September 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 41%"><font style="font: 10pt Times New Roman, Times, Serif">Systems</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,696,964</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">715,484</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,755,015</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,043,510</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Disposables, service and accessories</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,258,252</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,839,995</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">19,515,125</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">21,035,002</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Sublease</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">246,532</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">739,593</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total revenue</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8,201,748</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,555,479</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,009,733</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">22,078,512</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company&#8217;s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $1.0 million as of September 30, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The following information summarizes the Company&#8217;s contract assets and liabilities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30,&#160;2019</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December 31,&#160;2018</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 63%"><font style="font: 10pt Times New Roman, Times, Serif">Contract Assets - Unbilled Receivables</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">314,494</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251,867</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Customer deposits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41,860</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">487,086</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Product shipped, revenue deferred</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">645,199</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">645,199</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred service and license fees</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,157,232</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,100,402</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total deferred revenue</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,844,291</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,232,687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Less: Long-term deferred revenue</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(560,508</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(407,151</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total current deferred revenue</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,283,783</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,825,536</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Revenue recognized for the nine months ended September 30, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $5.4 million and $5.1 million respectively.</p> 2020-06-30 0.045 35791927 572612 2339810 2382662 5295084 485150 739592 246531 34100000 Yes Yes false 1000000 300000 66721079 1756757 -1449 6585000 5610121 2.05 2.05 23100000 5610 0.001 0.001 23780 23900 10000000 10000000 5610121 133329 -33271 -2515 84954 10631938 10626328 10631938 10626328 5610 5610 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.35in">Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019, excluding sublease income, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>September 30, 2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 79%"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 17%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">572,612</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,339,810</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,382,662</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">2022 and thereafter</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Total lease payments</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,295,084</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 20pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Interest</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(485,150</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Present value of lease liabilities</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,809,934</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> 5929749 5960475 1 12935740 7117 1 12928623 7117276 666 31650559 3686302 11570566 10796072 200000 1000000 1000000 Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details. EX-101.SCH 7 stxs-20190930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid Expenses and Other Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Long-Term Debt and Credit Facilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Convertible Preferred Stock and Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Product Warranty Provisions link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Prepaid Expenses and Other Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Product Warranty Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Leases - Schedule of Lease Costs and Other Lease Information (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Leases - Schedule of Future Minimum Operating Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Long-Term Debt and Credit Facilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Product Warranty Provisions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Product Warranty Provisions - Schedule of Accrued Warranty (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 stxs-20190930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 stxs-20190930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 stxs-20190930_lab.xml XBRL LABEL FILE Product and Service [Axis] Systems [Member] Disposables, Service and Accessories [Member] Contract Assets - Unbilled Receivables [Member] Product Shipped, Revenue Deferred [Member] Deferred Service and License Fees [Member] Property, Plant and Equipment, Type [Axis] Equipment [Member] Leasehold Improvements [Member] Credit Facility [Axis] Revolving Credit Facility [Member] Exercise Price Range [Axis] Range One [Member] Range Two [Member] Range Three [Member] Range Four [Member] Plan Name [Axis] 2012 Stock Incentive Plan [Member] Award Type [Axis] Restricted Stock Units [Member] Range [Axis] Minimum [Member] Maximum [Member] Range Five [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Treasury Stock [Member] Accumulated Deficit [Member] Class of Stock [Axis] Convertible Preferred Stock [Member] Customer Deposits [Member] Series A Convertible Preferred Stock [Member] Warrant [Member] Concentration Risk Benchmark [Axis] Revenue from System Delivery and Installation [Member] Disposable Revenue [Member] Royalty Revenue [Member] Other Recurring Revenue [Member] Sublease Revenue [Member] Stock Options and Stock Appreciation Rights [Member] Title of Individual [Axis] Primary Lender [Member] Variable Rate [Axis] Prime Rate [Member] Income Tax Authority [Axis] Series B Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update 2016-02 [Member] Sale of Stock [Axis] Private Placement [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net of allowance of $368,191 and $398,847 in 2019 and 2018, respectively Inventories, net Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Other assets Total assets Liabilities and stockholders' equity Current liabilities: Accounts payable Accrued liabilities Deferred revenue Current portion of operating lease liabilities Total current liabilities Long-term deferred revenue Operating lease liabilities Other liabilities Total liabilities Series A - Convertible preferred stock: Convertible preferred stock, Series A, par value $0.001; 23,780 and 23,900 shares outstanding at 2019 and 2018 Stockholders' equity: Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 and no shares outstanding at 2019 and 2018 Common stock, par value $0.001; 300,000,000 shares authorized, 66,677,111 and 59,058,297 shares issued at 2019 and 2018, respectively Additional paid in capital Treasury stock, 4,015 shares at 2019 and 2018 Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Accounts receivable, allowance Series A Convertible Preferred Stock, par value Series A Convertible Preferred Stock, shares outstanding Series B Preferred Stock, par value Series B Preferred Stock, shares authorized Series B Preferred Stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Treasury stock, shares Statement [Table] Statement [Line Items] Revenue: Sublease Total revenue Cost of revenue: Sublease Total cost of revenue Gross margin Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Operating loss Other income Interest income (expense) Net income (loss) Cumulative dividend on convertible preferred stock Loss attributable to common stockholders Net loss per share attributable to common stockholders: Basic Diluted Weighted average number of common shares and equivalents: Basic Diluted Beginning Balance Beginning Balance, Shares Issuance of common stock Issuance of common stock, shares Issuance of common stock and warrants Issuance of common stock and warrants, Shares Share-based compensation Share-based compensation, shares Components of net income (loss) Employee stock purchase plan Employee stock purchase plan, Shares Cumulative catchup for adoption of ASC 606 Preferred stock issuance Preferred stock issuance, shares Preferred stock conversion Preferred stock conversion, shares Ending Balance Ending Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities Net income (loss) Adjustments to reconcile net income (loss) to cash used in operating activities: Depreciation Amortization of intangibles Amortization of deferred finance costs Non-cash lease expense Share-based compensation Loss on asset disposal Adjustment of warrants Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other current assets Other assets Accounts payable Accrued liabilities Deferred revenue Operating lease liability Other liabilities Net cash used in operating activities Cash flows from investing activities Purchase of fixed assets Net cash used in investing activities Cash flows from financing activities Proceeds from issuance of stock, net of issuance costs Proceeds from warrant exercise Net cash provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventories Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses and Other Assets Property, Plant and Equipment [Abstract] Property and Equipment Leases [Abstract] Leases Payables and Accruals [Abstract] Accrued Liabilities Debt Disclosure [Abstract] Long-Term Debt and Credit Facilities Stockholders' Equity Note [Abstract] Convertible Preferred Stock and Stockholders' Equity Product Warranties Disclosures [Abstract] Product Warranty Provisions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Presentation Financial Instruments Revenue and Costs of Revenue Assets Recognized from the Costs to Obtain a Contract with a Customer Share-Based Compensation Net Income (Loss) Per Common Share ("EPS") Recently Issued Accounting Pronouncements Schedule of Revenue Disaggregated by Type Summary of Contract Assets and Liabilities Computation of Basic and Diluted Earnings Per Share Schedule of Inventories Schedule of Prepaid Expenses and Other Assets Schedule of Property and Equipment Schedule of Lease Costs and Other Lease Information Schedule of Future Minimum Operating Lease Payments Schedule of Accrued Liabilities Summary of Option and Stock Appreciation Rights Activity Summary of Restricted Stock Unit Activity Schedule of Accrued Warranty Installed base Antidilutive Securities [Axis] Revenues percentage Remaining performance obligation Revenue recognized Capitalized contract acquisition costs Share-based compensation, requisite service period Potential common shares excluded from diluted earnings per share Weighted average exercise price Exercise price of warrants Total deferred revenue Less: Long-term deferred revenue Total current deferred revenue Net loss attributable to common stockholders Weighted average number of common shares and equivalents: Basic EPS Diluted EPS Raw materials Work in process Finished goods Reserve for obsolescence Total inventory Prepaid expenses Prepaid commissions Deposits Total prepaid expenses and other assets Less: Noncurrent prepaid expenses and other assets Total current prepaid expenses and other assets Gross property and equipment Less: Accumulated depreciation Net property and equipment Schedule of Operating Leased Assets [Table] Operating Leased Assets [Line Items] Lease Arrangement, Type [Axis] Weighted average discount rate for operating leases Weighted average remaining lease term for operating lease term Right of use assets Undiscounted future cash flows to be received under the sublease 2019 Undiscounted future cash flows to be received under the sublease 2020 Undiscounted future cash flows to be received under the sublease 2021 Operating lease cost Short-term lease cost Sublease income Total lease cost Cash paid within operating cash flows 2019 2020 2021 2022 and thereafter Total lease payments Less: Interest Present value of lease liabilities Accrued salaries, bonus, and benefits Accrued licenses and maintenance fees Accrued warranties Accrued taxes Accrued professional services Other Total accrued liabilities Less: Long term accrued liabilities Total current accrued liabilities Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Line of credit maturity date Line of credit facility, maximum borrowing capacity Line of credit interest rate Line of credit facility, current borrowing capacity Total liquidity Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Statistical Measurement [Axis] Number of stockholders votes Dividends declared Dividends paid Sale of stock, number of shares sold Sale of stock, price per share Preferred stock, par or stated value Conversion price per share Net proceeds received Number of preferred stock issued Preferred stock, par value Preferred stock, conversion price Common stock issuable from warrants Preferred stock dividend rate Preferred stock redemption, triggering event, percent of common stock sold threshold Warrants exercisable date Increased in stockholders' equity Increased in common shares outstanding Increase in number of shares authorized for issuance under the plan Remaining shares available for issuance Total compensation cost not yet recognized Weighted average amortization period of total compensation cost not yet recognized Number of Options/SARs, Outstanding, Beginning Balance Number of Options/SARs, Granted Number of Options/SARs, Exercised Number of Options/SARs, Forfeited Number of Options/SARs, Outstanding, Ending Balance Range of Exercise Price, Lower Limit Range of Exercise Price, Upper Limit Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Weighted Average Exercise Price per Share, Granted Weighted Average Exercise Price per Share, Exercised Weighted Average Exercise Price per Share, Forfeited Weighted Average Exercise Price per Share, Outstanding, Ending Balance Number of Restricted Stock Units, Outstanding, December 31, 2018 Number of Restricted Stock Units, Granted Number of Restricted Stock Units, Vested Number of Restricted Stock Units, Forfeited Number of Restricted Stock Units, Outstanding, June 30, 2019 Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2018 Weighted Average Grant Date Fair Value per Unit, Granted Weighted Average Grant Date Fair Value per Unit, Vested Weighted Average Grant Date Fair Value per Unit, Forfeited Weighted Average Grant Date Fair Value per Unit, Outstanding, June 30, 2019 Standard product warranty coverage term Warranty accrual, beginning of the fiscal period Accrual adjustment for product warranty Payments made Warranty accrual, end of the fiscal period Carrying value as of the balance sheet date of obligations incurred through that date and payable for license and maintenance fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Issuance of common stock and warrants, shares. Biosense Webster Inc [Member] Contract Assets - Unbilled Receivables [Member] Country Other Than U.S. [Member] Customer Deposits [Member] Customer [Member] Deferred Service and License Fees [Member] Demonstration And Assembly [Member] Disposable Revenue [Member] Disposables, Service and Accessories [Member] Stock Option and Stock Appreciation Rights (SARs) [Member] Employee Stock Purchase Plan (&amp;#8220;ESPP&amp;#8221;) [Member] Exchange Warrants [Member] January 10, 2019 [Member] New Directors [Member] Non-employee Directors [Member] Non-Streamline Period [Member] Number of stockholders votes. Office Sublease [Member] Options to Purchase Common Stock [Member] Other Recurring Revenue [Member] Preferred stock par value per share. Preferred stock redemption, triggering event, Percent of common stock sold threshold Prepaid commissions, Current And Noncurrent Product Shipped, Revenue Deferred [Member] Range Five [Member]. PIPE Warrants [Member] Range of Exercise Prices Five [Member] Range of Exercise Prices Four [Member] Range of Exercise Prices One [Member] Range of Exercise Prices Seven [Member] Range of Exercise Prices Six [Member] Range of Exercise Prices Three [Member] Range of Exercise Prices Two [Member] PIPE Warrants [Member] PIPE Warrants [Member] PIPE Warrants [Member] Revenue from System Delivery and Installation [Membe Royalty Revenue [Member] Series A Convertible Preferred Stock and Accumulated Dividends [Member] Series A Convertible Preferred Stock [Membe Series A Convertible Preferred Stock Series [Member] Standard product warranty, coverage term Stock Award Plans [Member] Streamline Period [Member] The total number Niobe ES systems installed. Systems [Member] Time-Based Restricted Shares [Member] 2012 Stock Incentive Plan [Member] 2009 Employee Stock Purchase Plan ("ESPP") [Member] Unimproved Space [Member] Warrants Issued August 2013 [Member] Warrants Issued September 2016 [Member] Contract asset and liability [Policy Text Block] Sublease Revenue [Member]. Stock Options and Stock Appreciation Rights [Member] Primary Lender [Member] Increased in common shares outstanding. Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year. Cost of subleased portion of operating lease. Convertible securities, Conversion price per share. Series B Convertible Preferred Stock [Member] Sublease [Member] Undiscounted future cash flows to be received under the sublease reminder of fiscal year. Undiscounted future cash flows to be received under the sublease year two. Undiscounted future cash flows to be received under the sublease year three. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Treasury Stock, Common, Value Stockholders' Equity Attributable to Parent Liabilities and Equity CostOfSublease Gross Profit Operating Expenses Operating Income (Loss) Preferred Stock Dividends, Income Statement Impact Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Common Stock, Shares, Outstanding Share-based Payment Arrangement, Noncash Expense Gain (Loss) on Disposition of Assets Derivative, Gain (Loss) on Derivative, Net Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Productive Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Inventory Valuation Reserves Prepaid Expense and Other Assets Prepaid Expense and Other Assets, Noncurrent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Lease, Cost Lessee, Operating Lease, Liability, Payments, Due Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accrued Liabilities [Default Label] Other Accrued Liabilities, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Standard and Extended Product Warranty Accrual, Decrease for Payments EX-101.PRE 11 stxs-20190930_pre.xml XBRL PRESENTATION FILE XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories
9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Inventories

3. Inventories

 

Inventories consist of the following:

 

    September 30, 2019     December 31, 2018  
Raw materials   $ 2,831,977     $ 2,686,870  
Work in process     275,745       2,594  
Finished goods     2,308,165       2,963,013  
Reserve for obsolescence     (3,869,171 )     (4,460,811 )
Total inventory   $ 1,546,716     $ 1,191,666  

XML 14 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details)
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options/SARs, Outstanding, Beginning Balance | shares 1,165,086
Number of Options/SARs, Granted | shares 992,000
Number of Options/SARs, Exercised | shares (35,328)
Number of Options/SARs, Forfeited | shares (177,502)
Number of Options/SARs, Outstanding, Ending Balance | shares 1,944,256
Weighted Average Exercise Price per Share, Outstanding, Beginning Balance $ 2.54
Weighted Average Exercise Price per Share, Granted 2.04
Weighted Average Exercise Price per Share, Exercised 0.90
Weighted Average Exercise Price per Share, Forfeited 4.50
Weighted Average Exercise Price per Share, Outstanding, Ending Balance 2.13
Range One [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 43.90
Range Two [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 2.03
Range of Exercise Price, Upper Limit 2.89
Range Three [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 2.15
Range Four [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit 43.90
Range Five [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Range of Exercise Price, Lower Limit 0.74
Range of Exercise Price, Upper Limit $ 36.20
XML 15 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Oct. 31, 2019
Document And Entity Information    
Entity Registrant Name Stereotaxis, Inc.  
Entity Central Index Key 0001289340  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   66,721,079
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Total
Beginning Balance at Dec. 31, 2017 $ 5,960,475 $ 22,806 $ 450,748,403 $ (205,999) $ (477,132,808) $ (26,567,598)
Beginning Balance, Shares at Dec. 31, 2017 23,900 22,805,731        
Issuance of common stock and warrants   $ 35,793 26,813,524 26,849,317
Issuance of common stock and warrants, Shares   35,792,593        
Share-based compensation   $ 382 465,611 465,993
Share-based compensation, shares   382,356        
Components of net income (loss)   686,730 686,730
Employee stock purchase plan   $ 63 44,412 44,475
Employee stock purchase plan, Shares   63,484   1    
Cumulative catchup for adoption of ASC 606   294,561 [1] 294,561 [1]
Ending Balance at Sep. 30, 2018 $ 5,960,475   $ 59,044 478,071,950 (205,999) (476,151,517) 1,773,478
Ending Balance, Shares at Sep. 30, 2018 23,900   59,044,164        
Beginning Balance at Jun. 30, 2018 $ 5,960,475 $ 58,933 477,910,692 (205,999) (476,035,222) 1,728,404
Beginning Balance, Shares at Jun. 30, 2018 23,900 58,933,384        
Issuance of common stock   $ 1 1
Issuance of common stock, shares   666        
Share-based compensation   $ 88 145,461 145,549
Share-based compensation, shares   88,444        
Components of net income (loss)   (116,295) (116,295)
Employee stock purchase plan   $ 22 15,797 15,819
Employee stock purchase plan, Shares   21,670        
Ending Balance at Sep. 30, 2018 $ 5,960,475   $ 59,044 478,071,950 (205,999) (476,151,517) 1,773,478
Ending Balance, Shares at Sep. 30, 2018 23,900   59,044,164        
Beginning Balance at Dec. 31, 2018 $ 5,960,475 $ 59,058 478,179,574 (205,999) (476,721,490) 1,311,143
Beginning Balance, Shares at Dec. 31, 2018 23,900 59,058,297        
Issuance of common stock and warrants   $ 7,164 12,878,144 12,885,308
Issuance of common stock and warrants, Shares   7,163,760        
Share-based compensation   $ 207 1,380,488 1,380,695
Share-based compensation, shares   206,962        
Components of net income (loss)   (3,506,790) (3,506,790)
Employee stock purchase plan   $ 32 54,770 54,802
Employee stock purchase plan, Shares   32,064        
Preferred stock issuance $ 5,610 10,626,328 10,631,938
Preferred stock issuance, shares 5,610,121          
Preferred stock conversion $ (30,726)   $ 216 $ 30,510 $ 30,726
Preferred stock conversion, shares (120)   216,028
Ending Balance at Sep. 30, 2019 $ 5,929,749 $ 5,610 $ 66,677 $ 503,149,814 $ (205,999) $ (480,228,280) $ 22,787,822
Ending Balance, Shares at Sep. 30, 2019 23,780 5,610,121 66,677,111        
Beginning Balance at Jun. 30, 2019 $ 5,948,953 $ 59,383 479,127,279 (205,999) (480,272,028) (1,291,365)
Beginning Balance, Shares at Jun. 30, 2019 23,855 59,383,038        
Issuance of common stock   $ 7,117 12,928,623 12,935,740
Issuance of common stock, shares   7,117,276        
Share-based compensation   $ 33 425,680 425,713
Share-based compensation, shares   32,500        
Components of net income (loss)   43,748 43,748
Employee stock purchase plan   $ 8 22,836 22,844
Employee stock purchase plan, Shares   8,307        
Preferred stock issuance $ 5,610 10,626,328 10,631,938
Preferred stock issuance, shares 5,610,121        
Preferred stock conversion $ (19,204)   $ 136 19,068 19,204
Preferred stock conversion, shares (75)   135,990        
Ending Balance at Sep. 30, 2019 $ 5,929,749 $ 5,610 $ 66,677 $ 503,149,814 $ (205,999) $ (480,228,280) $ 22,787,822
Ending Balance, Shares at Sep. 30, 2019 23,780 5,610,121 66,677,111        
[1] Represents the adjustments related to the adoption of new accounting standards. See Note 2 for details.
XML 17 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2019
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

    September 30, 2019     December 31, 2018  
Equipment   $ 6,389,366     $ 6,739,939  
Leasehold improvements     2,488,505       2,684,065  
      8,877,871       9,424,004  
Less: Accumulated depreciation     (8,607,120 )     (9,080,311 )
Net property and equipment   $ 270,751     $ 343,693  

XML 18 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Product Warranty Provisions (Tables)
9 Months Ended
Sep. 30, 2019
Product Warranties Disclosures [Abstract]  
Schedule of Accrued Warranty

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

    September 30, 2019     December 31, 2018  
Warranty accrual, beginning of the fiscal period   $ 149,464     $ 164,365  
Accrual adjustment for product warranty     41,023       34,253  
Payments made     (44,019 )     (49,154 )
Warranty accrual, end of the fiscal period   $ 146,468     $ 149,464  

XML 19 R36.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Details Narrative) - USD ($)
Sep. 30, 2019
Jan. 02, 2019
Dec. 31, 2018
Operating Leased Assets [Line Items]      
Weighted average discount rate for operating leases 9.00%    
Weighted average remaining lease term for operating lease term 2 years 2 months 30 days    
Right of use assets $ 4,771,187  
Undiscounted future cash flows to be received under the sublease 2019 200,000    
Undiscounted future cash flows to be received under the sublease 2020 1,000,000    
Undiscounted future cash flows to be received under the sublease 2021 $ 1,000,000    
Accounting Standards Update 2016-02 [Member]      
Operating Leased Assets [Line Items]      
Right of use assets   $ 6,200,000  
XML 20 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Accounting Policies [Abstract]        
Net income (loss) $ 43,748 $ (116,295) $ (3,506,790) $ 686,730
Cumulative dividend on convertible preferred stock (360,647) (361,447) (1,071,351) (1,072,553)
Net loss attributable to common stockholders $ (316,899) $ (477,742) $ (4,578,141) $ (385,823)
Weighted average number of common shares and equivalents: 64,294,153 59,008,219 61,405,083 49,733,553
Basic EPS $ (0.00) $ (0.01) $ (0.07) $ (0.01)
Diluted EPS $ (0.00) $ (0.01) $ (0.07) $ (0.01)
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment
9 Months Ended
Sep. 30, 2019
Property, Plant and Equipment [Abstract]  
Property and Equipment

5. Property and Equipment

 

    September 30, 2019     December 31, 2018  
Equipment   $ 6,389,366     $ 6,739,939  
Leasehold improvements     2,488,505       2,684,065  
      8,877,871       9,424,004  
Less: Accumulated depreciation     (8,607,120 )     (9,080,311 )
Net property and equipment   $ 270,751     $ 343,693  

 

Certain prior year amounts have been reclassified to conform to the 2019 presentation.

XML 22 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Preferred Stock and Stockholders' Equity
9 Months Ended
Sep. 30, 2019
Stockholders' Equity Note [Abstract]  
Convertible Preferred Stock and Stockholders' Equity

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends and the conditions of the revolving line of credit agreement. No dividends have been declared or paid as of September 30, 2019.

 

2019 Equity Financing and Series B Convertible Preferred Stock

 

On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, in a private placement, agreed to issue and sell to the investors an aggregate of 6,585,000 shares of the Company’s common stock, $0.001 par value per share, at a price of $2.05 per share and 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholder’s equity section of the Company’s Balance Sheet.

 

The Company received net proceeds of approximately $23.1 million, after offering expenses. The Company plans to use the funds for general corporate purposes.

 

Series A Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 with a stated value of $1,000 per share which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The convertible preferred shares are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The convertible preferred shares bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the convertible preferred shares. Each holder of convertible preferred shares has the right to require us to redeem such holder’s convertible preferred shares upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the convertible preferred shares in the event of a defined change of control. The convertible preferred shares rank senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the convertible preferred shares are subject to conditions for redemption that are outside the Company’s control, the convertible preferred shares are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the convertible preferred stock (the “SPA Warrants”) have an exercise price equal to $0.70 per share subject to adjustments as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations. The warrants were originally puttable upon the occurrence of certain events outside of the Company’s control, and were classified as liabilities under Accounting Standards Codification (“ASC”) Topic 480-10. The calculated fair value of the warrants was periodically re-measured with any changes in value recognized in “Other income (expense)” in the Statements of Operations.

 

The warrants were modified on February 28, 2018 to allow for a reduction in the exercise price from $0.70 per share to $0.28 per share for a period between March 1, 2018 and March 5, 2018. Any holder who exercised warrants at the reduced strike price was required to enter into a lock-up agreement with the Company agreeing not to sell the warrants or the common shares received upon exercise of the warrants for a period of 18 months following March 12, 2018. Additionally, the beneficial ownership limitation related to the warrants was modified and the right of holders to require the Company to redeem their SPA Warrants in exchange for cash in certain circumstances was eliminated. Following these modifications, the warrants were no longer subject to liability accounting and were reclassified to equity. During the restricted exercise period, Stereotaxis received exercise notices for 35,791,927 warrants and received an aggregate of $10.0 million in cash from the warrant exercise. As a result of these transactions, total stockholders’ equity increased by $27 million and common shares outstanding increased by 35,791,927 shares. The Consent and Amendment and the Amended and Restated Form of Warrants are available in a Form 8-K filed with the Securities and Exchange Commission on March 6, 2018.

 

Stock Award Plans

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

On June 5, 2013, June 10, 2014, May 24, 2016, and May 23, 2017, the shareholders approved amendments to the Plan, which were previously approved and adopted by the Compensation Committee of the Board of Directors of the Company. Under each of the amendments on June 5, 2013 and June 10, 2014, the number of shares authorized for issuance under the Plan was increased by one million shares. The amendment on May 24, 2016 increased the number of shares authorized for issuance under the Plan by 1.5 million shares, and the amendment on May 23, 2017 increased the number of shares authorized for issuance under the Plan by 4.0 million shares. At September 30, 2019, the Company had 3,203,531 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At September 30, 2019, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $1.7 million. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the nine month period ended September 30, 2019 is as follows:

 

    Number of Options/SARs     Range of Exercise Price   Weighted Average Exercise Price per Share  
                 
Outstanding, December 31, 2018     1,165,086     $0.74 - $43.90   $ 2.54  
Granted     992,000     $2.03 - $2.89   $ 2.04  
Exercised     (35,328 )   $0.74 - $2.15   $ 0.90  
Forfeited     (177,502 )   $0.74 - $43.90   $ 4.50  
Outstanding, September 30, 2019     1,944,256     $0.74 - $36.20   $ 2.13  

 

A summary of the restricted stock unit activity for the nine month period ended September 30, 2019 is as follows:

 

    Number of
Restricted Stock
Units
    Weighted Average
Grant Date Fair
Value per Unit
 
             
Outstanding, December 31, 2018     647,649     $ 0.83  
Granted     420,000     $ 1.98  
Vested     (206,962 )   $ 1.36  
Forfeited     (16,600 )   $ 0.76  
Outstanding, September 30, 2019     844,087     $ 1.28  

EXCEL 23 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 24 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the nine month period ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

Financial Instruments

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

Revenue and Costs of Revenue

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented 8% and 5% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 33% of revenue for the nine months ended September 30, 2019 and 2018.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 10% of revenue for the nine months ended September 30, 2019 and 2018.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 46% and 52% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning in 2019. Sublease revenue represented 3% of revenue for the nine months ended September 30, 2019.

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Systems   $ 1,696,964     $ 715,484     $ 1,755,015     $ 1,043,510  
Disposables, service and accessories     6,258,252       6,839,995       19,515,125       21,035,002  
Sublease     246,532       -       739,593       -  
Total revenue   $ 8,201,748     $ 7,555,479     $ 22,009,733     $ 22,078,512  

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $1.0 million as of September 30, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

    September 30, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 314,494     $ 251,867  
                 
Customer deposits     41,860       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     5,157,232       5,100,402  
Total deferred revenue     5,844,291       6,232,687  
Less: Long-term deferred revenue     (560,508 )     (407,151 )
Total current deferred revenue   $ 5,283,783     $ 5,825,536  

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the nine months ended September 30, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $5.4 million and $5.1 million respectively.

Assets Recognized from the Costs to Obtain a Contract with a Customer

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

Share-Based Compensation

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

Net Income (Loss) Per Common Share ("EPS")

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Net income (loss)   $ 43,748     $ (116,295 )   $ (3,506,790 )   $ 686,730  
Cumulative dividend on convertible preferred stock     (360,647 )     (361,447 )     (1,071,351 )     (1,072,553 )
Net loss attributable to common stockholders   $ (316,899 )   $ (477,742 )   $ (4,578,141 )   $ (385,823 )
                                 
Weighted average number of common shares and equivalents:     64,294,153       59,008,219       61,405,083       49,733,553  
Basic EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )
Diluted EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common because all such securities are anti-dilutive for all periods presented. The Company had no unearned restricted shares during any period.

 

As of September 30, 2019, the Company had 1,944,256 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.13 per share, 584,616 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,175,861 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock, 5,610,121 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock and accumulated dividends, and 844,087 shares of unvested restricted share units.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease revenue and the related cost as Sublease cost of revenue. See Note 6 for additional details.

XML 25 R37.htm IDEA: XBRL DOCUMENT v3.19.3
Leases - Schedule of Lease Costs and Other Lease Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Leases [Abstract]        
Operating lease cost $ 585,588   $ 1,756,759  
Short-term lease cost 19,671   58,311  
Sublease income (246,532) (739,593)
Total lease cost 358,727   1,075,477  
Cash paid within operating cash flows $ 612,533   $ 1,840,023  
XML 26 R33.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories - Schedule of Inventories (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 2,831,977 $ 2,686,870
Work in process 275,745 2,594
Finished goods 2,308,165 2,963,013
Reserve for obsolescence (3,869,171) (4,460,811)
Total inventory $ 1,546,716 $ 1,191,666
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.19.3
Subsequent Events
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

12. Subsequent Events

 

None.

XML 28 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Assets
9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Assets

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

 

    September 30, 2019     December 31, 2018  
Prepaid expenses   $ 500,537     $ 401,972  
Prepaid commissions     331,523       304,585  
Deposits     404,304       455,508  
Total prepaid expenses and other assets     1,236,364       1,162,065  
Less: Noncurrent prepaid expenses and other assets     (214,042 )     (198,365 )
Total current prepaid expenses and other assets   $ 1,022,322     $ 963,700  

XML 29 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Long-Term Debt and Credit Facilities
9 Months Ended
Sep. 30, 2019
Debt Disclosure [Abstract]  
Long-Term Debt and Credit Facilities

8. Long-Term Debt and Credit Facilities

 

The Company has had a working capital line of credit with its primary lender, Silicon Valley Bank, since 2004. The working capital line of credit matures on June 30, 2020. The revolving line of credit is secured by substantially all of the Company’s assets. The maximum available under the line is $5.0 million subject to the value of collateralized assets and the interest rate is equal to the prime rate subject to a floor of 4.5%. The Company is required under the revolving line of credit to maintain its primary operating account and the majority of its cash and investment balances in accounts with its primary lender.

 

On June 27, 2019, the Company entered into a Second Amendment to and Reinstatement of Third Amended and Restated Loan and Security Agreement with Silicon Valley Bank to extend the maturity of the revolving line of credit to June 30, 2020 under substantially identical terms to the prior agreement.

 

As of September 30, 2019, the Company had no outstanding balance under the revolving line of credit. Draws on the line of credit were made based on the borrowing capacity one week in arrears. As of September 30, 2019, the Company had a borrowing capacity of $2.4 million based on the Company’s collateralized assets. The Company’s total liquidity as of September 30, 2019, was $34.1 million which included cash and cash equivalents of $31.7 million.

XML 31 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenue:        
Sublease $ 246,532 $ 739,593
Total revenue 8,201,748 7,555,479 22,009,733 22,078,512
Cost of revenue:        
Sublease 246,531 739,592
Total cost of revenue 1,831,593 1,633,458 4,391,138 4,287,855
Gross margin 6,370,155 5,922,021 17,618,595 17,790,657
Operating expenses:        
Research and development 1,751,081 2,000,780 7,405,462 5,995,800
Sales and marketing 3,120,632 2,819,101 9,666,975 9,911,514
General and administrative 1,539,648 1,215,920 4,186,277 3,753,703
Total operating expenses 6,411,361 6,035,801 21,258,714 19,661,017
Operating loss (41,206) (113,780) (3,640,119) (1,870,360)
Other income 2,590,361
Interest income (expense) 84,954 (2,515) 133,329 (33,271)
Net income (loss) 43,748 (116,295) (3,506,790) 686,730
Cumulative dividend on convertible preferred stock (360,647) (361,447) (1,071,351) (1,072,553)
Loss attributable to common stockholders $ (316,899) $ (477,742) $ (4,578,141) $ (385,823)
Net loss per share attributable to common stockholders:        
Basic $ (0.00) $ (0.01) $ (0.07) $ (0.01)
Diluted $ (0.00) $ (0.01) $ (0.07) $ (0.01)
Weighted average number of common shares and equivalents:        
Basic 64,294,153 59,008,219 61,405,083 49,733,553
Diluted 64,294,153 59,008,219 61,405,083 49,733,553
Systems [Member]        
Revenue:        
Total revenue $ 1,696,964 $ 715,484 $ 1,755,015 $ 1,043,510
Cost of revenue:        
Total cost of revenue 665,463 596,869 722,828 1,257,980
Disposables, Service and Accessories [Member]        
Revenue:        
Total revenue 6,258,252 6,839,995 19,515,125 21,035,002
Cost of revenue:        
Total cost of revenue $ 919,599 $ 1,036,589 $ 2,928,718 $ 3,029,875
XML 32 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the nine month period ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019 or for future operating periods.

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 as filed with the Securities and Exchange Commission (SEC) on March 15, 2019.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

Revenue and Costs of Revenue

 

The Company adopted Accounting Standards Codification Topic 606 (“ASC 606”), Revenue from Contracts with Customers, on January 1, 2018.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For multiple-element arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were not material for the periods presented. Revenue from system delivery and installation represented 8% and 5% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 33% of revenue for the nine months ended September 30, 2019 and 2018.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 10% of revenue for the nine months ended September 30, 2019 and 2018.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for one year following installation. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 46% and 52% of revenue for the nine months ended September 30, 2019 and 2018, respectively.

 

Sublease Revenue:

 

The adoption of new lease accounting guidance as of January 1, 2019 requires the Company to record sublease income as revenue beginning in 2019. Sublease revenue represented 3% of revenue for the nine months ended September 30, 2019.

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Systems   $ 1,696,964     $ 715,484     $ 1,755,015     $ 1,043,510  
Disposables, service and accessories     6,258,252       6,839,995       19,515,125       21,035,002  
Sublease     246,532       -       739,593       -  
Total revenue   $ 8,201,748     $ 7,555,479     $ 22,009,733     $ 22,078,512  

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $1.0 million as of September 30, 2019. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

    September 30, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 314,494     $ 251,867  
                 
Customer deposits     41,860       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     5,157,232       5,100,402  
Total deferred revenue     5,844,291       6,232,687  
Less: Long-term deferred revenue     (560,508 )     (407,151 )
Total current deferred revenue   $ 5,283,783     $ 5,825,536  

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the nine months ended September 30, 2019 and 2018, that was included in the deferred revenue balance at the beginning of each reporting period was $5.4 million and $5.1 million respectively.

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.3 million as of September 30, 2019. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recorded at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recorded at the time of sale. Cost of revenue from services and license fees are recorded when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

The Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

Net Income (Loss) per Common Share (“EPS”)

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to common shareholders by the number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our Convertible Preferred Stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our Convertible Preferred Stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our Convertible Preferred Stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Net income (loss)   $ 43,748     $ (116,295 )   $ (3,506,790 )   $ 686,730  
Cumulative dividend on convertible preferred stock     (360,647 )     (361,447 )     (1,071,351 )     (1,072,553 )
Net loss attributable to common stockholders   $ (316,899 )   $ (477,742 )   $ (4,578,141 )   $ (385,823 )
                                 
Weighted average number of common shares and equivalents:     64,294,153       59,008,219       61,405,083       49,733,553  
Basic EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )
Diluted EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )

 

The Company did not include any portion of unearned restricted stock units, outstanding options, stock appreciation rights, or warrants in the calculation of diluted loss per common because all such securities are anti-dilutive for all periods presented. The Company had no unearned restricted shares during any period.

 

As of September 30, 2019, the Company had 1,944,256 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $2.13 per share, 584,616 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,175,861 shares of common stock issuable upon the conversion of Series A Convertible Preferred Stock, 5,610,121 shares of common stock issuable upon the conversion of Series B Convertible Preferred Stock and accumulated dividends, and 844,087 shares of unvested restricted share units.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2019, the Company adopted the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842), and all subsequent ASUs that modified Topic 842, which sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. Accounting Standards Codification (“ASC 842”) supersedes the previous lease standard, ASC 840 Leases. The Company adopted ASU 2016-02 using the alternative modified transition method. Under this method, the cumulative-effect adjustment to the opening balance of retained earnings is recognized on the date of adoption with prior periods not restated. There was no cumulative-effect adjustment recorded on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs. In addition, the new standard provides practical expedients for an entity’s ongoing accounting. The Company elected the practical expedients for ongoing accounting of (1) the election for certain classes of underlying asset to not separate non-lease components from lease components and (2) the election for short-term lease recognition exemption for all leases that qualify. For the Company, as a lessee, the primary impact of adopting ASC 842 was the balance sheet recognition of the right-of-use asset and lease liability for the operating leases. Under the new standard, as a lessor, the Company will record the sublease proceeds as Sublease revenue and the related cost as Sublease cost of revenue. See Note 6 for additional details.

XML 33 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 130 311 1 true 39 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://stereotaxis.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://stereotaxis.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://stereotaxis.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business Sheet http://stereotaxis.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Inventories Sheet http://stereotaxis.com/role/Inventories Inventories Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid Expenses and Other Assets Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets Prepaid Expenses and Other Assets Notes 10 false false R11.htm 00000011 - Disclosure - Property and Equipment Sheet http://stereotaxis.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Leases Sheet http://stereotaxis.com/role/Leases Leases Notes 12 false false R13.htm 00000013 - Disclosure - Accrued Liabilities Sheet http://stereotaxis.com/role/AccruedLiabilities Accrued Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Long-Term Debt and Credit Facilities Sheet http://stereotaxis.com/role/Long-termDebtAndCreditFacilities Long-Term Debt and Credit Facilities Notes 14 false false R15.htm 00000015 - Disclosure - Convertible Preferred Stock and Stockholders' Equity Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity Convertible Preferred Stock and Stockholders' Equity Notes 15 false false R16.htm 00000016 - Disclosure - Product Warranty Provisions Sheet http://stereotaxis.com/role/ProductWarrantyProvisions Product Warranty Provisions Notes 16 false false R17.htm 00000017 - Disclosure - Commitments and Contingencies Sheet http://stereotaxis.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://stereotaxis.com/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Inventories (Tables) Sheet http://stereotaxis.com/role/InventoriesTables Inventories (Tables) Tables http://stereotaxis.com/role/Inventories 21 false false R22.htm 00000022 - Disclosure - Prepaid Expenses and Other Assets (Tables) Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssetsTables Prepaid Expenses and Other Assets (Tables) Tables http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://stereotaxis.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://stereotaxis.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Leases (Tables) Sheet http://stereotaxis.com/role/LeasesTables Leases (Tables) Tables http://stereotaxis.com/role/Leases 24 false false R25.htm 00000025 - Disclosure - Accrued Liabilities (Tables) Sheet http://stereotaxis.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://stereotaxis.com/role/AccruedLiabilities 25 false false R26.htm 00000026 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables Convertible Preferred Stock and Stockholders' Equity (Tables) Tables http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity 26 false false R27.htm 00000027 - Disclosure - Product Warranty Provisions (Tables) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsTables Product Warranty Provisions (Tables) Tables http://stereotaxis.com/role/ProductWarrantyProvisions 27 false false R28.htm 00000028 - Disclosure - Description of Business (Details Narrative) Sheet http://stereotaxis.com/role/DescriptionOfBusinessDetailsNarrative Description of Business (Details Narrative) Details http://stereotaxis.com/role/DescriptionOfBusiness 28 false false R29.htm 00000029 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 00000030 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfRevenueDisaggregatedByTypeDetails Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) Details 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfContractAssetsAndLiabilitiesDetails Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) Details 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies-ComputationOfBasicAndDilutedEarningsPerShareDetails Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Details 32 false false R33.htm 00000033 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://stereotaxis.com/role/Inventories-ScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 33 false false R34.htm 00000034 - Disclosure - Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets-ScheduleOfPrepaidExpensesAndOtherAssetsDetails Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Details 34 false false R35.htm 00000035 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://stereotaxis.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 35 false false R36.htm 00000036 - Disclosure - Leases (Details Narrative) Sheet http://stereotaxis.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://stereotaxis.com/role/LeasesTables 36 false false R37.htm 00000037 - Disclosure - Leases - Schedule of Lease Costs and Other Lease Information (Details) Sheet http://stereotaxis.com/role/Leases-ScheduleOfLeaseCostsAndOtherLeaseInformationDetails Leases - Schedule of Lease Costs and Other Lease Information (Details) Details 37 false false R38.htm 00000038 - Disclosure - Leases - Schedule of Future Minimum Operating Lease Payments (Details) Sheet http://stereotaxis.com/role/Leases-ScheduleOfFutureMinimumOperatingLeasePaymentsDetails Leases - Schedule of Future Minimum Operating Lease Payments (Details) Details 38 false false R39.htm 00000039 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://stereotaxis.com/role/AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails Accrued Liabilities - Schedule of Accrued Liabilities (Details) Details 39 false false R40.htm 00000040 - Disclosure - Long-Term Debt and Credit Facilities (Details Narrative) Sheet http://stereotaxis.com/role/Long-termDebtAndCreditFacilitiesDetailsNarrative Long-Term Debt and Credit Facilities (Details Narrative) Details http://stereotaxis.com/role/Long-termDebtAndCreditFacilities 40 false false R41.htm 00000041 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Details Narrative) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative Convertible Preferred Stock and Stockholders' Equity (Details Narrative) Details http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables 41 false false R42.htm 00000042 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity-SummaryOfOptionAndStockAppreciationRightsActivityDetails Convertible Preferred Stock and Stockholders' Equity - Summary of Option and Stock Appreciation Rights Activity (Details) Details 42 false false R43.htm 00000043 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity-SummaryOfRestrictedStockUnitActivityDetails Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Product Warranty Provisions (Details Narrative) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsDetailsNarrative Product Warranty Provisions (Details Narrative) Details http://stereotaxis.com/role/ProductWarrantyProvisionsTables 44 false false R45.htm 00000045 - Disclosure - Product Warranty Provisions - Schedule of Accrued Warranty (Details) Sheet http://stereotaxis.com/role/ProductWarrantyProvisions-ScheduleOfAccruedWarrantyDetails Product Warranty Provisions - Schedule of Accrued Warranty (Details) Details 45 false false All Reports Book All Reports stxs-20190930.xml stxs-20190930.xsd stxs-20190930_cal.xml stxs-20190930_def.xml stxs-20190930_lab.xml stxs-20190930_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 34 R43.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Preferred Stock and Stockholders' Equity - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units [Member]
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Restricted Stock Units, Outstanding, December 31, 2018 | shares 647,649
Number of Restricted Stock Units, Granted | shares 420,000
Number of Restricted Stock Units, Vested | shares (206,962)
Number of Restricted Stock Units, Forfeited | shares (16,600)
Number of Restricted Stock Units, Outstanding, June 30, 2019 | shares 844,087
Weighted Average Grant Date Fair Value per Unit, Outstanding, December 31, 2018 | $ / shares $ 0.83
Weighted Average Grant Date Fair Value per Unit, Granted | $ / shares 1.98
Weighted Average Grant Date Fair Value per Unit, Vested | $ / shares 1.36
Weighted Average Grant Date Fair Value per Unit, Forfeited | $ / shares 0.76
Weighted Average Grant Date Fair Value per Unit, Outstanding, June 30, 2019 | $ / shares $ 1.28
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Assets (Tables)
9 Months Ended
Sep. 30, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Assets

Prepaid expenses and other assets consist of the following:

 

    September 30, 2019     December 31, 2018  
Prepaid expenses   $ 500,537     $ 401,972  
Prepaid commissions     331,523       304,585  
Deposits     404,304       455,508  
Total prepaid expenses and other assets     1,236,364       1,162,065  
Less: Noncurrent prepaid expenses and other assets     (214,042 )     (198,365 )
Total current prepaid expenses and other assets   $ 1,022,322     $ 963,700  

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Preferred Stock and Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2019
Stockholders' Equity Note [Abstract]  
Summary of Option and Stock Appreciation Rights Activity

A summary of the option and stock appreciation rights activity for the nine month period ended September 30, 2019 is as follows:

 

    Number of Options/SARs     Range of Exercise Price   Weighted Average Exercise Price per Share  
                 
Outstanding, December 31, 2018     1,165,086     $0.74 - $43.90   $ 2.54  
Granted     992,000     $2.03 - $2.89   $ 2.04  
Exercised     (35,328 )   $0.74 - $2.15   $ 0.90  
Forfeited     (177,502 )   $0.74 - $43.90   $ 4.50  
Outstanding, September 30, 2019     1,944,256     $0.74 - $36.20   $ 2.13  

Summary of Restricted Stock Unit Activity

A summary of the restricted stock unit activity for the nine month period ended September 30, 2019 is as follows:

 

    Number of
Restricted Stock
Units
    Weighted Average
Grant Date Fair
Value per Unit
 
             
Outstanding, December 31, 2018     647,649     $ 0.83  
Granted     420,000     $ 1.98  
Vested     (206,962 )   $ 1.36  
Forfeited     (16,600 )   $ 0.76  
Outstanding, September 30, 2019     844,087     $ 1.28  

XML 37 R12.htm IDEA: XBRL DOCUMENT v3.19.3
Leases
9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Leases

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. The Company determines if an arrangement contains a lease at inception. For the Company, Accounting Standards Codification (“ASC 842”) primarily affected the accounting treatment for operating lease agreements in which the Company is the lessee.

 

The Company leases its facilities under operating leases, which were previously not recognized on the Company’s balance sheets. With the adoption of ASC 842, operating lease agreements are required to be recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At September 30, 2019, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 2.25 years.

 

The following table represents lease costs and other lease information.

 

    Three Months Ended     Nine Months Ended  
    September 30, 2019     September 30, 2019  
Operating lease cost   $ 585,588     $ 1,756,759  
Short-term lease cost     19,671       58,311  
Sublease income     (246,532 )     (739,593 )
Total lease cost   $ 358,727     $ 1,075,477  
                 
Cash paid within operating cash flows   $ 612,533     $ 1,840,023  

 

The initial recognition of the right of use assets was $6.2 million. Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019, excluding sublease income, were as follows:

 

    September 30, 2019  
2019   $ 572,612  
2020     2,339,810  
2021     2,382,662  
2022 and thereafter     -  
Total lease payments   $ 5,295,084  
Less: Interest     (485,150 )
Present value of lease liabilities   $ 4,809,934  

 

The undiscounted future cash flows to be received under the sublease are $0.2 million in 2019, $1.0 million in 2020 and $1.0 million in 2021.

XML 38 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Product Warranty Provisions
9 Months Ended
Sep. 30, 2019
Product Warranties Disclosures [Abstract]  
Product Warranty Provisions

10. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

    September 30, 2019     December 31, 2018  
Warranty accrual, beginning of the fiscal period   $ 149,464     $ 164,365  
Accrual adjustment for product warranty     41,023       34,253  
Payments made     (44,019 )     (49,154 )
Warranty accrual, end of the fiscal period   $ 146,468     $ 149,464  

XML 39 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Dec. 31, 2017
Payables and Accruals [Abstract]      
Accrued salaries, bonus, and benefits $ 1,481,466 $ 1,491,844  
Accrued licenses and maintenance fees 483,879 577,389  
Accrued warranties 146,468 149,464 $ 164,365
Accrued taxes 204,679 192,268  
Accrued professional services 216,938 489,017  
Other 368,771 383,960  
Total accrued liabilities 2,902,201 3,283,942  
Less: Long term accrued liabilities (260,947) (641,461)  
Total current accrued liabilities $ 2,641,254 $ 2,642,481  
XML 40 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Gross property and equipment $ 8,877,871 $ 9,424,004
Less: Accumulated depreciation (8,607,120) (9,080,311)
Net property and equipment 270,751 343,693
Equipment [Member]    
Gross property and equipment 6,389,366 6,739,939
Leasehold Improvements [Member]    
Gross property and equipment $ 2,488,505 $ 2,684,065
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Total deferred revenue $ 5,844,291 $ 6,232,687
Less: Long-term deferred revenue (560,508) (407,151)
Total current deferred revenue 5,283,783 5,825,536
Contract Assets - Unbilled Receivables [Member]    
Total deferred revenue 314,494 251,867
Customer Deposits [Member]    
Total deferred revenue 41,860 487,086
Product Shipped, Revenue Deferred [Member]    
Total deferred revenue 645,199 645,199
Deferred Service and License Fees [Member]    
Total deferred revenue $ 5,157,232 $ 5,100,402
XML 42 R2.htm IDEA: XBRL DOCUMENT v3.19.3
Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 31,650,559 $ 10,796,072
Accounts receivable, net of allowance of $368,191 and $398,847 in 2019 and 2018, respectively 3,830,395 5,021,111
Inventories, net 1,546,716 1,191,666
Prepaid expenses and other current assets 1,022,322 963,700
Total current assets 38,049,992 17,972,549
Property and equipment, net 270,751 343,693
Operating lease right-of-use assets 4,771,187
Other assets 214,042 198,365
Total assets 43,305,972 18,514,607
Current liabilities:    
Accounts payable 1,031,975 1,726,360
Accrued liabilities 2,641,254 2,642,481
Deferred revenue 5,283,783 5,825,536
Current portion of operating lease liabilities 2,235,465
Total current liabilities 11,192,477 10,194,377
Long-term deferred revenue 560,508 407,151
Operating lease liabilities 2,574,469
Other liabilities 260,947 641,461
Total liabilities 14,588,401 11,242,989
Series A - Convertible preferred stock:    
Convertible preferred stock, Series A, par value $0.001; 23,780 and 23,900 shares outstanding at 2019 and 2018 5,929,749 5,960,475
Stockholders' equity:    
Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 and no shares outstanding at 2019 and 2018 5,610
Common stock, par value $0.001; 300,000,000 shares authorized, 66,677,111 and 59,058,297 shares issued at 2019 and 2018, respectively 66,677 59,058
Additional paid in capital 503,149,814 478,179,574
Treasury stock, 4,015 shares at 2019 and 2018 (205,999) (205,999)
Accumulated deficit (480,228,280) (476,721,490)
Total stockholders' equity 22,787,822 1,311,143
Total liabilities and stockholders' equity $ 43,305,972 $ 18,514,607
XML 43 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net income (loss) $ (3,506,790) $ 686,730
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation 88,774 394,154
Amortization of intangibles 49,491
Amortization of deferred finance costs 24,657
Non-cash lease expense 1,756,757
Share-based compensation 898,836 465,851
Loss on asset disposal 1,449
Adjustment of warrants (2,590,361)
Changes in operating assets and liabilities:    
Accounts receivable 1,190,716 (800,856)
Inventories (355,050) (55,486)
Prepaid expenses and other current assets (58,622) (131,116)
Other assets (15,677) (1,799)
Accounts payable (694,385) (80,066)
Accrued liabilities 480,632 (372,289)
Deferred revenue (388,396) 553,937
Operating lease liability (1,718,010)
Other liabilities (380,514) 86,204
Net cash used in operating activities (2,701,729) (1,769,500)
Cash flows from investing activities    
Purchase of fixed assets (15,832) (255,554)
Net cash used in investing activities (15,832) (255,554)
Cash flows from financing activities    
Proceeds from issuance of stock, net of issuance costs 23,572,048 44,621
Proceeds from warrant exercise 9,864,697
Net cash provided by financing activities 23,572,048 9,909,318
Net increase in cash and cash equivalents 20,854,487 7,884,264
Cash and cash equivalents at beginning of period 10,796,072 3,686,302
Cash and cash equivalents at end of period $ 31,650,559 $ 11,570,566
XML 44 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Product Warranty Provisions - Schedule of Accrued Warranty (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Product Warranties Disclosures [Abstract]    
Warranty accrual, beginning of the fiscal period $ 149,464 $ 164,365
Accrual adjustment for product warranty 41,023 34,253
Payments made (44,019) (49,154)
Warranty accrual, end of the fiscal period $ 146,468 $ 149,464
XML 45 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Convertible Preferred Stock and Stockholders' Equity (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 07, 2019
USD ($)
$ / shares
shares
Mar. 05, 2018
USD ($)
$ / shares
May 23, 2017
shares
May 24, 2016
shares
Jun. 10, 2014
shares
Jun. 05, 2013
shares
Sep. 30, 2016
$ / shares
shares
Sep. 30, 2019
USD ($)
Integer
$ / shares
shares
Sep. 30, 2019
USD ($)
Integer
$ / shares
shares
Sep. 30, 2018
USD ($)
Dec. 31, 2018
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of stockholders votes | Integer               1 1    
Dividends declared | $                  
Dividends paid | $                    
Common stock, par value               $ 0.001 $ 0.001   $ 0.001
Preferred stock, par or stated value               0.001 0.001   $ 0.001
Exercise price of warrants               $ 0.70 $ 0.70    
Warrants exercisable date                 Sep. 29, 2021    
Proceeds from warrant exercise | $                 $ 9,864,697  
Increased in stockholders' equity | $                 $ 27,000,000    
Increased in common shares outstanding | shares                 35,791,927    
Remaining shares available for issuance | shares               3,203,531 3,203,531    
Total compensation cost not yet recognized | $               $ 1,700,000 $ 1,700,000    
Weighted average amortization period of total compensation cost not yet recognized                 4 years    
2012 Stock Incentive Plan [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Increase in number of shares authorized for issuance under the plan | shares     4,000,000 1,500,000 1,000,000 1,000,000          
Maximum [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Exercise price of warrants   $ 0.70                  
Minimum [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Exercise price of warrants   $ 0.28                  
Series A Convertible Preferred Stock [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Preferred stock, par or stated value             $ 1,000        
Number of preferred stock issued | shares             24,000        
Preferred stock, par value             $ 0.001        
Preferred stock, conversion price             $ 0.65        
Common stock issuable from warrants | shares             36,923,078        
Preferred stock dividend rate             6.00%        
Preferred stock redemption, triggering event, percent of common stock sold threshold             50.00%        
Common Stock [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Number of preferred stock issued | shares                    
Warrant [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Exercise price of warrants               $ 0.70 $ 0.70    
Proceeds from warrant exercise | $   $ 10,000,000                  
Private Placement [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Net proceeds received | $ $ 23,100,000                    
Private Placement [Member] | Common Stock [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Sale of stock, number of shares sold | shares 6,585,000                    
Common stock, par value $ 0.001                    
Sale of stock, price per share $ 2.05                    
Private Placement [Member] | Series B Convertible Preferred Stock [Member]                      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                      
Sale of stock, number of shares sold | shares 5,610,121                    
Preferred stock, par or stated value $ 0.001                    
Conversion price per share $ 2.05                    
XML 47 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Revenue Disaggregated by Type

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Systems   $ 1,696,964     $ 715,484     $ 1,755,015     $ 1,043,510  
Disposables, service and accessories     6,258,252       6,839,995       19,515,125       21,035,002  
Sublease     246,532       -       739,593       -  
Total revenue   $ 8,201,748     $ 7,555,479     $ 22,009,733     $ 22,078,512  

Summary of Contract Assets and Liabilities

The following information summarizes the Company’s contract assets and liabilities:

 

    September 30, 2019     December 31, 2018  
Contract Assets - Unbilled Receivables   $ 314,494     $ 251,867  
                 
Customer deposits     41,860       487,086  
Product shipped, revenue deferred     645,199       645,199  
Deferred service and license fees     5,157,232       5,100,402  
Total deferred revenue     5,844,291       6,232,687  
Less: Long-term deferred revenue     (560,508 )     (407,151 )
Total current deferred revenue   $ 5,283,783     $ 5,825,536  

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted EPS:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2019     2018     2019     2018  
Net income (loss)   $ 43,748     $ (116,295 )   $ (3,506,790 )   $ 686,730  
Cumulative dividend on convertible preferred stock     (360,647 )     (361,447 )     (1,071,351 )     (1,072,553 )
Net loss attributable to common stockholders   $ (316,899 )   $ (477,742 )   $ (4,578,141 )   $ (385,823 )
                                 
Weighted average number of common shares and equivalents:     64,294,153       59,008,219       61,405,083       49,733,553  
Basic EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )
Diluted EPS   $ (0.00 )   $ (0.01 )   $ (0.07 )   $ (0.01 )

XML 48 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Leases (Tables)
9 Months Ended
Sep. 30, 2019
Leases [Abstract]  
Schedule of Lease Costs and Other Lease Information

The following table represents lease costs and other lease information.

 

    Three Months Ended     Nine Months Ended  
    September 30, 2019     September 30, 2019  
Operating lease cost   $ 585,588     $ 1,756,759  
Short-term lease cost     19,671       58,311  
Sublease income     (246,532 )     (739,593 )
Total lease cost   $ 358,727     $ 1,075,477  
                 
Cash paid within operating cash flows   $ 612,533     $ 1,840,023  

Schedule of Future Minimum Operating Lease Payments

Future minimum payments for operating leases with initial or remaining terms of one year or more as of September 30, 2019, excluding sublease income, were as follows:

 

    September 30, 2019  
2019   $ 572,612  
2020     2,339,810  
2021     2,382,662  
2022 and thereafter     -  
Total lease payments   $ 5,295,084  
Less: Interest     (485,150 )
Present value of lease liabilities   $ 4,809,934  

XML 49 R28.htm IDEA: XBRL DOCUMENT v3.19.3
Description of Business (Details Narrative)
Sep. 30, 2019
Integer
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Installed base 125
XML 50 R44.htm IDEA: XBRL DOCUMENT v3.19.3
Product Warranty Provisions (Details Narrative)
9 Months Ended
Sep. 30, 2019
Product Warranties Disclosures [Abstract]  
Standard product warranty coverage term 1 year
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Long-Term Debt and Credit Facilities (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Debt Instrument [Line Items]    
Total liquidity $ 34,100,000  
Cash and cash equivalents 31,650,559 $ 10,796,072
Revolving Credit Facility [Member]    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity  
Line of credit facility, current borrowing capacity 2,400,000  
Revolving Credit Facility [Member] | Primary Lender [Member]    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity $ 5,000,000  
Revolving Credit Facility [Member] | Prime Rate [Member] | Primary Lender [Member]    
Debt Instrument [Line Items]    
Line of credit maturity date Jun. 30, 2020  
Line of credit interest rate 4.50%  
XML 52 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Balance Sheets (Parenthetical) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 368,191 $ 398,847
Series A Convertible Preferred Stock, par value $ 0.001 $ 0.001
Series A Convertible Preferred Stock, shares outstanding 23,780 23,900
Series B Preferred Stock, par value $ 0.001 $ 0.001
Series B Preferred Stock, shares authorized 10,000,000 10,000,000
Series B Preferred Stock, shares outstanding 5,610,121
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 66,677,111 59,058,297
Treasury stock, shares 4,015 4,015
XML 53 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Description of Business
9 Months Ended
Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced robotic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our products include the Genesis RMN® (Robotic Magnetic Navigation) System (“Genesis System”), the Niobe ES Robotic Magnetic Navigation System (“Niobe ES System”), Odyssey Information Management Solution (“Odyssey Solution”), the Vdrive Robotic Navigation System (“Vdrive System”), Stereotaxis Imaging Model S X-ray System, and related devices.

 

The Genesis and Niobe Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure. As of September 30, 2019, the Company had an installed base of 125 Niobe ES Systems.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates all lab information enabling doctors to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

Our Vdrive System provides navigation and stability for diagnostic and therapeutic devices designed to improve interventional procedures. The Vdrive System complements the robotic magnetic navigation systems’ control of therapeutic catheters for fully remote procedures and enables single-operator workflow and is sold as two options, the Vdrive System and the Vdrive Duo System. In addition to the Vdrive System and the Vdrive Duo System, we also manufacture and market various disposable components which can be manipulated by these systems.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

The Niobe System, Odyssey Workstation, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. The Genesis System and the V-CAS Deflect catheter advancement system have been CE Marked for sale in the Europe. Stereotaxis Imaging Model S System is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

XML 54 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Remaining performance obligation $ 1,000,000    
Revenue recognized 5,400,000 $ 5,100,000  
Capitalized contract acquisition costs $ 300,000    
Share-based compensation, requisite service period 4 years    
Weighted average exercise price $ 2.13   $ 2.54
Exercise price of warrants $ 0.70    
Series A Convertible Preferred Stock [Member]      
Potential common shares excluded from diluted earnings per share 43,175,861    
Series B Convertible Preferred Stock [Member]      
Potential common shares excluded from diluted earnings per share 5,610,121    
Warrant [Member]      
Potential common shares excluded from diluted earnings per share 584,616    
Exercise price of warrants $ 0.70    
Stock Options and Stock Appreciation Rights [Member]      
Potential common shares excluded from diluted earnings per share 1,944,256    
Weighted average exercise price $ 2.13    
Restricted Stock Units [Member]      
Potential common shares excluded from diluted earnings per share 844,087    
Revenue from System Delivery and Installation [Member]      
Revenues percentage 8.00% 5.00%  
Disposable Revenue [Member]      
Revenues percentage 33.00% 33.00%  
Royalty Revenue [Member]      
Revenues percentage 10.00% 10.00%  
Other Recurring Revenue [Member]      
Revenues percentage 46.00% 52.00%  
Sublease Revenue [Member]      
Revenues percentage 3.00%    
XML 55 R21.htm IDEA: XBRL DOCUMENT v3.19.3
Inventories (Tables)
9 Months Ended
Sep. 30, 2019
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consist of the following:

 

    September 30, 2019     December 31, 2018  
Raw materials   $ 2,831,977     $ 2,686,870  
Work in process     275,745       2,594  
Finished goods     2,308,165       2,963,013  
Reserve for obsolescence     (3,869,171 )     (4,460,811 )
Total inventory   $ 1,546,716     $ 1,191,666  

XML 56 R25.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities

Accrued liabilities consist of the following:

 

    September 30, 2019     December 31, 2018  
Accrued salaries, bonus, and benefits   $ 1,481,466     $ 1,491,844  
Accrued licenses and maintenance fees     483,879       577,389  
Accrued warranties     146,468       149,464  
Accrued taxes     204,679       192,268  
Accrued professional services     216,938       489,017  
Other     368,771       383,960  
Total accrued liabilities     2,902,201       3,283,942  
Less: Long term accrued liabilities     (260,947 )     (641,461 )
Total current accrued liabilities   $ 2,641,254     $ 2,642,481  

XML 57 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Accrued Liabilities
9 Months Ended
Sep. 30, 2019
Payables and Accruals [Abstract]  
Accrued Liabilities

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

    September 30, 2019     December 31, 2018  
Accrued salaries, bonus, and benefits   $ 1,481,466     $ 1,491,844  
Accrued licenses and maintenance fees     483,879       577,389  
Accrued warranties     146,468       149,464  
Accrued taxes     204,679       192,268  
Accrued professional services     216,938       489,017  
Other     368,771       383,960  
Total accrued liabilities     2,902,201       3,283,942  
Less: Long term accrued liabilities     (260,947 )     (641,461 )
Total current accrued liabilities   $ 2,641,254     $ 2,642,481  

 

Certain prior year amounts have been reclassified to conform to the 2019 presentation.

XML 58 R17.htm IDEA: XBRL DOCUMENT v3.19.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

11. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

XML 59 R34.htm IDEA: XBRL DOCUMENT v3.19.3
Prepaid Expenses and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 500,537 $ 401,972
Prepaid commissions 331,523 304,585
Deposits 404,304 455,508
Total prepaid expenses and other assets 1,236,364 1,162,065
Less: Noncurrent prepaid expenses and other assets (214,042) (198,365)
Total current prepaid expenses and other assets $ 1,022,322 $ 963,700
XML 60 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Type (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Total revenue $ 8,201,748 $ 7,555,479 $ 22,009,733 $ 22,078,512
Sublease 246,532 739,593
Systems [Member]        
Total revenue 1,696,964 715,484 1,755,015 1,043,510
Disposables, Service and Accessories [Member]        
Total revenue $ 6,258,252 $ 6,839,995 $ 19,515,125 $ 21,035,002
XML 61 R38.htm IDEA: XBRL DOCUMENT v3.19.3
Leases - Schedule of Future Minimum Operating Lease Payments (Details)
Sep. 30, 2019
USD ($)
Leases [Abstract]  
2019 $ 572,612
2020 2,339,810
2021 2,382,662
2022 and thereafter
Total lease payments 5,295,084
Less: Interest (485,150)
Present value of lease liabilities $ 4,809,934
ZIP 62 0001493152-19-017289-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-19-017289-xbrl.zip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end